| References |
| 1. |
Adachi, H.,
N. Toda,
S. Hayashi,
M. Noguchi,
T. Suzuki,
K. Torizuka,
H. Yajima, and
K. Koyama.
Mechanism of the excitatory action of motilin on isolated rabbit intestine.
Gastroenterology
80:
783–788,
1981.
|
| 2. |
Aggestrup, S., and
S. Jensen.
Effect of regulatory peptides on the vagally stimulated lower esophageal sphincter pressure in pigs.
Scand. J. Gastroenterol.
21:
761–763,
1986.
|
| 3. |
Ahmad, S.,
I. Berezin,
J. P. Vincent, and
E. E. Daniel.
Neurotensin receptors in canine intestinal smooth muscle: preparation of plasma membranes and characterization of 125I‐Tyr3‐neurotensin binding.
Biochim. Biophys. Acta
896:
224–238,
1987.
|
| 4. |
Ahmad, S.,
C. Y. Kwan,
J. P. Vincent,
A. K. Grover,
C. Y. Jung, and
E. E. Daniel.
Target size analysis of neurotensin receptors.
Peptides Fayetteville
8:
195–197,
1987.
|
| 5. |
Aizawa, I.,
Z. Itoh,
V. Harris, and
H. Unger.
Plasma somatostatin‐like immunoreactivity during the interdigestive period in the dog.
J. Clin Invest.
68:
206–213,
1981.
|
| 6. |
Akil, H.,
S. J. Watson,
E. Young,
M. E. Lewis,
H. Khachaturian, and
J. M. Walker.
Endogenous opioids: biology and function.
Annu. Rev. Neurosci.
7:
223–255,
1984.
|
| 7. |
Al‐Saffar, A., and
S. Rosell.
Effects of neurotensin and neurotensin analogues on the migrating myoelectric complexes in the small intestine of rats.
Acta Physiol. Scand.
112:
203–208,
1981.
|
| 8. |
Alumets, J.,
J. Fahrenkrug,
R. Håkanson,
O. B. Schaffalitzky de Muckadell,
F. Sundler, and
R. Uddman.
A rich VIP nerve supply is characteristic of sphincters.
Nature Lond.
280:
155–156,
1979.
|
| 9. |
Amer, M. S.
Studies with cholecystokinin in vitro. III. Mechanisms of the effect on isolated rabbit gallbladder strips.
J. Pharmacol. Exp. Ther.
183:
527–534,
1972.
|
| 10. |
Amer, M. S.
Cyclic guanosine 3′,5′‐monophosphate and gallbladder contraction.
Gastroenterology
67:
333–337,
1974.
|
| 11. |
Amer, M. S., and
W. E. Becvar.
A sensitive in vitro method for the assay of cholecystokinin.
J. Endocrinol.
43:
637–642,
1969.
|
| 12. |
Amer, M. S., and
G. R. McKinney.
Studies with cholecystokinin in vitro. IV. Effect of cholecystokinin and related peptides on phosphodiesterase.
J. Pharmacol. Exp. Ther.
183:
535–548,
1972.
|
| 13. |
Anastasi, A.,
U. Erspamer, and
R. Endean.
Isolation and amino acid sequence of caerulein the active decapeptide of the skin of Hyla caerulein.
Arch. Biochem. Biophys.
125:
57–68,
1968.
|
| 14. |
Andersson, R. G.
Relationship between cyclic AMP phosphodiesterase activity, calcium and contraction in intestinal smooth muscle.
Acta Physiol. Scand.
87:
348–358,
1973.
|
| 15. |
Andersson, S.,
S. Rosell,
U. Hjelmquist,
D. Chang, and
K. Folkers.
Inhibition of gastric and intestinal motor activity in dogs by [Gln4]neurotensin.
Acta Physiol. Scand.
100:
231–235,
1977.
|
| 16. |
Andrews, P. C., and
J. E. Dixon.
Biosynthesis and processing of the somatostatin family of peptide hormones.
Scand. J. Gastroenterol.
21,
Suppl. 119:
22–28,
1986.
|
| 17. |
Andrews, P. L. R.
The non‐adrenergic non‐cholinergic innervation of the stomach.
Arch. Int. Pharmacodyn. Ther.
280,
Suppl. 2:
84–109,
1986.
|
| 18. |
Andrews, P. L. R., and
I. N. C. Lawes.
Characteristics of the vagally driven non‐adrenergic non‐cholinergic inhibitory innervation of the ferret gastric corpus.
J. Physiol. Land.
363:
1–20,
1985.
|
| 19. |
Angel, F.,
V. L. W. Go,
P. F. Schmaltz, and
J. H. Szurszewski.
Vasoactive intestinal polypeptide: a putative transmitter in the canine gastric muscularis mucosa.
J. Physiol. Lond.
341:
641–654,
1983.
|
| 20. |
Angel, F.,
V. L. W. Go, and
J. H. Szurszewski.
Innervation of the muscularis mucosae of canine proximal colon.
J. Physiol. Lond.
357:
93–108,
1984.
|
| 21. |
Araki, K.,
S. Tachibana,
M. Uchiyama,
T. Nakajima, and
T. Yasuhara.
Isolation and structure of a new active peptide “xenopsin” on the smooth muscle, especially on a strip of fundus from a rat stomach, from the skin of Xenopus laevis.
Chem. Pharm. Bull. Tokyo
21:
2801–2804,
1973.
|
| 22. |
Bailey, S. J.,
R. L. Featherstone,
C. C. Jordan, and
I. K. M. Morton.
An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes.
Br. J. Pharmacol.
87:
79–85,
1986.
|
| 23. |
Bardon, T., and
Y. Ruckebusch.
Comparative effects of opiate agonists on proximal and distal colonic motility in dogs.
Eur. J. Pharmacol.
110:
329–334,
1985.
|
| 24. |
Bartho, L., and
P. Holzer.
Search for a physiological role of substance P in gastrointestinal motility.
Neuroscience
16:
1–32,
1985.
|
| 25. |
Bartho, L.,
P. Holzer,
J. Donnener, and
F. Lembeck.
Effects of substance P, cholecystokinin octapeptide, bombesin and neurotensin on the peristaltic reflex of the guinea‐pig ileum in the absence and in the presence of atropine.
Naunyn‐Schmiedeberg's Arch. Pharmacol.
321:
321–328,
1982.
|
| 26. |
Bartho, L.,
P. Holzer, and
F. Lembeck.
Sympathetic control of Substance P‐releasing enteric neurones in the guinea pig ileum.
Neurosci. Lett.
38:
291–296,
1983.
|
| 27. |
Bartho, L.,
P. Holzer,
F. Lembeck, and
J. Szolcsanyi.
Evidence that the contractile response of the guinea‐pig ileum to capsaicin is due to release of substance P.
J. Physiol. Lond.
332:
157–167,
1982.
|
| 28. |
Bartho, L.,
B. Sebok, and
J. Szolcsanyi.
Indirect evidence for the inhibition of enteric substance P neurones by opiate agonists but not by capsaicin.
Eur. J. Pharmacol.
77:
273–279,
1982.
|
| 29. |
Bauer, V., and
O. Matusak.
The non‐adrenergic non‐cholinergic innervation and transmission in the small intestine.
Arch. Int. Pharmacodyn. Ther.
280,
Suppl. 2:
137–163,
1986.
|
| 30. |
Behar, J., and
P. Binancani.
Effect of cholecystokinin octapeptide on lower esophageal sphincter.
Gastroenterology
73:
57–61,
1977.
|
| 31. |
Behar, J., and
P. Biancani.
Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder.
J. Clin. Invest.
66:
1231–1239,
1980.
|
| 32. |
Behar, J., and
P. Biancani.
Neural control of the sphincter of Oddi. Physiologic role of enkephalins on the regulation of basal sphincter of Oddi motor activity in the cat.
Gastroenterology
86:
134–141,
1984.
|
| 33. |
Behar, J.,
S. Field, and
C. Marin.
Effect of glucagon, secretin and vasoactive intestinal polypeptide on the feline lower esophageal sphincter: mechanism of action.
Gastroenterology
77:
1001–1007,
1979.
|
| 34. |
Beinfeld, M. C., and
G. J. Bailey.
The distribution of motilin‐like peptides in rhesus monkey brain as determined by radioimmunoassay.
Neurosci. Lett.
54:
345–350,
1985.
|
| 35. |
Beinfeld, M. C., and
D. M. Korchak.
The regional distribution and the chemical, chromatographic and immunologic characterization of motilin brain peptides: the evidence for a difference between brain and intestinal motilin‐immunoreactive peptides.
J. Neurosci.
5:
2502–2509,
1985.
|
| 36. |
Beinfeld, M. C.,
D. M. Korchak,
G. Nilaver, and
T. M. O'Dorisio.
The development of motilin, cholecystokinin and vasoactive intestinal peptide immunoreactivity in the forebrain and hindbrain of the rat, as determined by radioimmunoassay.
Dev. Brain Res.
10:
146–150,
1983.
|
| 37. |
Benham, C. D., and
T. B. Bolton.
Comparison of the excitatory actions of substance P, carbachol, histamine and prostaglandin F2α on the smooth muscle of the taenia of the guinea‐pig caecum.
Br. J. Pharmacol.
80:
409–420,
1983.
|
| 38. |
Bennett, A.
Effect of gastrin on isolated smooth muscle preparations.
Nature Lond.
208:
170–173,
1965.
|
| 39. |
Berezin, I.,
S. Sheppard,
E. E. Daniel, and
N. Yanaihara.
Ultrastructural immunocytochemical distribution of VIP‐like immunoreactivity in dog ileum.
Regul. Pept.
11:
287–298,
1985.
|
| 40. |
Bertaccini, G.,
H. Impicciatore, and
G. de Caro.
Action of caerulein and related substances on the pyloric sphincter of the anesthetized rat.
Eur. J. Pharmacol.
22:
320–324,
1973.
|
| 41. |
Beubler, E., and
F. Lembeck.
Inhibition of stimulated fluid secretion in the rat small and large intestine by opiate agonists.
Naunyn‐Schmiedeberg's Arch. Pharmacol.
306:
113–118,
1979.
|
| 42. |
Biancani, P.,
J. H. Walsh, and
J. Behar.
Vasoactive intestinal polypeptide. A neurotransmitter for lower esophageal sphincter relaxation.
J. Clin. Invest.
73:
963–967,
1984.
|
| 43. |
Biancani, P.,
J. H. Walsh, and
J. Behar.
Vasoactive intestinal peptide: a neurotransmitter for relaxation of the rabbit internal anal sphincter.
Gastroenterology
89:
867–874,
1985.
|
| 44. |
Bitar, K. N.,
P. Bradford,
J. W. Putney, and
G. M. Makhlouf.
Inositol triphosphate (InsP3): second messenger for mobilization of intracellular calcium during contraction of isolated muscle cells (Abstract).
Gastroenterology
88:
1326,
1985.
|
| 45. |
Bitar, K. N.,
P. Bradford,
J. W. Putney, and
G. M. Makhlouf.
Cytosolic calcium during contraction of isolated mammalian gastric muscle cells.
Science Wash. DC
232:
1143–1145,
1986.
|
| 46. |
Bitar, K. N.,
G. M. Burgess,
J. W. Putney, Jr., and
G. M. Makhlouf.
Source of activator calcium in isolated guinea pig and human gastric muscle cells.
Am. J. Physiol.
250
(Gastrointest. Liver Physiol. 13):
G280–G286,
1986.
|
| 47. |
Bitar, K. N., and
R. T. Jensen.
Binding of 125I‐VIP to isolated gastric smooth muscle cells (Abstract).
Gastroenterology
84:
1107,
1983.
|
| 48. |
Bitar, K. N., and
G. M. Makhlouf.
Cholinergic and CCK receptors on canine isolated gall bladder smooth muscle cells (Abstract).
Gastroenterology
80:
111,
1981.
|
| 49. |
Bitar, K. N., and
G. M. Makhlouf.
Receptors on smooth muscle cells: characterization by contraction and specific antagonists.
Am. J. Physiol.
242
(Gastrointest. Liver Physiol. 5):
G400–G407,
1982.
|
| 50. |
Bitar, K. N., and
G. M. Makhlouf.
Relaxation of isolated gastric smooth muscle cells by vasoactive intestinal peptide.
Science Wash. DC
216:
531–533,
1982.
|
| 51. |
Bitar, K. N., and
G. M. Makhlouf.
Selective presence of opiate receptors on intestinal circular muscle cells.
Life Sci.
37:
1545–1550,
1985.
|
| 52. |
Bitar, K. N.,
B. Saffouri, and
G. M. Makhlouf.
Cholinergic and peptidergic receptors on isolated human antral smooth muscle cells.
Gastroenterology
82:
832–837,
1982.
|
| 53. |
Bitar, K. N.,
A. M. Zfass, and
G. M. Makhlouf.
Interaction of acetylcholine and cholecystokinin with dispersed smooth muscle cells.
Am. J. Physiol.
237
(Endocrinol. Metab. Gastrointest. Physiol. 6):
E172–E176,
1979.
|
| 54. |
Björkroth, U.
Inhibition of smooth muscle contractions induced by capsaicin and electrical transmural stimulation by a substance P antagonist.
Acta Physiol. Scand. Suppl.
515:
11–16,
1983.
|
| 55. |
Blanquet, F.,
M. Bouvier, and
J. Gonella.
Effects of enkephalins and morphine on spontaneous electrical activity and on junction potentials elicited by parasympathetic nerve stimulation in cat and rabbit colon.
Br. J. Pharmacol.
77:
419–429,
1982.
|
| 56. |
Blanquet, F.,
M. Bouvier, and
J. Gonella.
Action of trimebutine in cat and rabbit colon: evidence of an opioid‐like effect.
J. Pharmacol. Exp. Ther.
234:
708–712,
1985.
|
| 57. |
Bodner, M.,
M. Fridkin, and
I. Gozes.
Coding sequences for vasoactive intestinal peptide and PHM‐27 peptide are located on two adjacent exons in the human genome.
Proc. Natl. Acad. Sci. USA
82:
3548–3551,
1985.
|
| 58. |
Bormans, V.,
T. L. Peeters, and
G. Vantrappen.
Motilin receptors in rabbit stomach and small intestine.
Regul. Pept.
15:
143–153,
1986.
|
| 59. |
Bornstein, J. C.,
R. A. North,
M. Costa, and
J. B. Furness.
Excitatory synaptic potentials due to activation of neurons with short projections in the myenteric plexus.
Neuroscience
11:
723–731,
1984.
|
| 60. |
Borody, T. J.,
D. J. Byrnes, and
D. A. Titchen.
Motilin and migrating myoelectric complexes in the pig and the dog.
Q. J. Exp. Physiol.
69:
875–890,
1984.
|
| 61. |
Borody, T. J.,
E. M. M. Quigley,
S. F. Phillips,
M. Wienbeck,
R. L. Tucker,
A. Haddad, and
A. R. Zinsmeister.
Effects of morphine and atropine on motility and transit in the human ileum.
Gastroenterology
89:
562–570,
1985.
|
| 62. |
Bouvier, M.,
G. Kirschner, and
J. Gonella.
Actions of morphine and enkephalins on the internal anal sphincter of the cat: relevance of the physiological role of opiates.
J. Auton. Nerv. Syst.
16:
219–232,
1986.
|
| 63. |
Bowen, J. C.,
W. Pawlick,
W.‐F. Fang, and
E. Jacobsen.
Pharmacologic effects of gastrointestinal hormones on intestinal oxygen consumption and blood flow.
Surgery St. Louis
78:
515–519,
1975.
|
| 64. |
Bowers, C. W.,
L. Y. Jan, and
Y. N. Jan.
A substance P‐like peptide in bullfrog autonomic nerve terminals: anatomy, biochemistry and physiology.
Neuroscience.
19:
343–356,
1986.
|
| 65. |
Bozou, J. C.,
S. Amar,
J. P. Vincent, and
P. Kitabgi.
Neurotensin‐mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells, involvement of the inhibitory GTP‐binding component of adenylate cyclase.
Mol. Pharmacol.
29:
489–496,
1986.
|
| 66. |
Brazeau, P.,
W. L. Vale,
R. Burgus,
N. Ling,
M. Butcher,
J. Rivier, and
R. Guillemin.
Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.
Science Wash. DC
179:
77–79,
1973.
|
| 67. |
Broccardo, M.,
V. Erspamer,
G. Falconieri Erspamer,
G. Improta,
A. Linari,
P. Melchiorri, and
P. C. Montecucchi.
Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin.
Br. J. Pharamacol.
73:
625–631,
1981.
|
| 68. |
Brown, D. R., and
R. J. Miller.
Adrenergic mediation of the intestinal antisecretory action of opiates administered into the central nervous system.
J. Pharmacol. Exp. Ther.
231:
114–119,
1984.
|
| 69. |
Brown, J. C.,
M. A. Cook, and
J. R. Dryburgh.
Motilin, a gastric motor activity stimulating polypeptide: the complete amino acid sequence.
Can. J. Biochem.
51:
533–537,
1973.
|
| 70. |
Brown, J. C.,
L. P. Johnson, and
D. F. Magee.
Effect of duodenal alkalization on gastric motility.
Gastroenterology
50:
333–339,
1966.
|
| 71. |
Brown, J. C.,
V. Mutt, and
J. Dryburgh.
The further purification of motilin, a gastric motor activity stimulating polypeptide from the mucosa of the small intestine of hogs.
Can. J. Physiol. Pharmacol.
49:
399–405,
1971.
|
| 72. |
Brown, J. H., and
D. Goldstein.
Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chicken heart cells.
Mol. Pharmacol.
30:
566–570,
1987.
|
| 73. |
Buck, S. H., and
E. Burcher.
The tachykinins: a family of peptides with a brood of ‘receptors.’
Trends Pharmacol. Sci.
7:
65–68,
1986.
|
| 74. |
Buck, S. H., and
E. Burcher.
Functional receptors and binding sites for tachykinins. (Letter to editor.)
Trends Pharmacol. Sci.
7:
302–303,
1986.
|
| 75. |
Buck, S. H., and
T. F. Burks.
The neuropharmacology of capsaicin: review of some recent observations.
Pharmacol. Rev.
38:
179–226,
1986.
|
| 76. |
Bueno, L.,
M. J. Fargeas,
J. Fioramonti, and
M. P. Primi.
Central control of intestinal motility by prostaglandins: a mediator of the actions of several peptides in rats and dogs.
Gastroenterology
88:
1888–1894,
1985.
|
| 77. |
Bueno, L., and
J. P. Ferre.
Central regulation of intestinal motility by somatostatin and cholecystokinin octapeptide.
Science Wash. DC
216:
1427–1429,
1982.
|
| 78. |
Bueno, L.,
J. P. Ferre,
J. Fioramonti, and
C. Honde.
Effects of intracerebroventricular administration of neurotensin, substance P and calcitonin on gastrointestinal motility in normal and vagotomized rats.
Regul. Pept.
6:
197–205,
1983.
|
| 79. |
Bueno, L.,
J. P. Ferre,
J. Fioramonti, and
M. Rukebusch.
Control of the antral motor response to feeding by gastric acid secretion in rats.
J. Physiol. Lond.
325:
43–50,
1982.
|
| 80. |
Bueno, L., and
J. Fioramonti.
A possible central serotoninergic mechanism involved in the effects of morphine on colonic motility in dog.
Eur. J. Pharmacol.
82:
147–153,
1982.
|
| 81. |
Bueno, L.,
J. Fioramonti,
C. Honde,
M. J. Fargeas, and
M. P. Primi.
Central and peripheral control of gastrointestinal and colonic motility by endogenous opiates in conscious dogs.
Gastroenterology
88:
549–556,
1985.
|
| 82. |
Bueno, L.,
J. Fioramonti,
V. Rayner, and
Y. Ruckebusch.
Effects of motilin, somatostatin and pancreatic polypeptide on the migrating myoelectric complex in pig and dog.
Gastroenterology
82:
1395–1402,
1982.
|
| 83. |
Bueno, L.,
J. Fioramenti, and
M. Ruckebusch.
Comparative effects of morphine and nalorphine on colonic motility in the conscious dog.
Eur. J. Pharmacol.
75:
239–245,
1981.
|
| 84. |
Bunnett, N. W.,
R. Kobayashi,
M. S. Orloff,
J. R. Reeve,
A. J. Turner, and
J. H. Walsh.
Catabolism of gastrin releasing peptide and substance P by gastric membrane‐bound peptidases.
Peptides Fayetteville
6:
277–283,
1985.
|
| 85. |
Bunnett, N. W.,
M. Mogard,
M. S. Orloff,
H. J. Corbett,
J. R. Reeve, Jr., and
J. H. Walsh.
Catabolism of neurotensin in interstitial fluid of the rat stomach.
Am. J. Physiol.
246
(Gastrointest. Liver Physiol. 9):
G675–G682,
1984.
|
| 86. |
Burcher, E.,
S. H. Buck,
W. Lovenberg, and
T. L. O'Donohue.
Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
J. Pharmacol. Exp. Ther.
236:
819–831,
1986.
|
| 87. |
Burks, T. F.,
L. D. Hirning,
J. J. Galligan, and
T. P. Davis.
Motility effects of opioid peptides in dog intestine.
Life Sci.
31:
2237–2240,
1982.
|
| 88. |
Burleigh, D. E., and
S. J. Trout.
Morphine attenuates cholinergic nerve activity in human isolated colonic muscle.
Br. J. Pharmacol.
88:
307–313,
1986.
|
| 89. |
Burleigh, D. E., and
A. D'Mello.
Neural and pharmacologic factors affecting motility of the internal anal sphincter.
Gastroenterology
84:
409–417,
1983.
|
| 90. |
Bury, R. W., and
M. L. Mashford.
A pharmacological investigation of synthetic substance P on the isolated guinea‐pig ileum.
Clin. Exp. Pharmacol. Physiol.
4:
453–461,
1977.
|
| 91. |
Bybee, D. E.,
F. C. Brown,
L. P. Georges,
D. O. Castell, and
J. E. McGuigan.
Somatostatin effects on lower esophageal sphincter function.
Am. J. Physiol.
237
(Endocrinol. Metab. Gastrointest. Physiol. 6):
E77–E81,
1979.
|
| 92. |
Camilleri, M.,
J.‐R. Malagelada,
V. Stangheluni,
A. R. Zinsmeister,
P. C. Kao, and
C. H. Li.
Dose‐related effects of synthetic human β‐endorphin and naloxone on fed gastrointestinal motility.
Am. J. Physiol
251
(Gastrointest. Liver Physiol 14):
G147–G154,
1986.
|
| 93. |
Canonico, P. L.,
M. A. Sortino,
C. Speciale, and
U. Scapagnini.
Neurotensin stimulates polyphosphoinositide breakdown and prolactin release in anterior pituitary cells in culture.
Mol. Cell. Endocrinol.
42:
215–220,
1985.
|
| 94. |
Carlquist, M.,
V. Mutt, and
H. Jornvall.
Isolation and characterization of bovine vasoactive intestinal peptide (VIP).
FEBS Lett.
108:
457–460,
1979.
|
| 95. |
Carraway, R. E.
A critical analysis of three approaches to radioimmunoassay of peptides: applications to the study of the neurotensin family.
Ann. NY Acad. Sci.
400:
17–36,
1982.
|
| 96. |
Carraway, R. E., and
C. F. Ferris.
Isolation, biological and chemical characterization, and synthesis of a neurotensin‐related hexapeptide from chicken intestine.
J. Biol. Chem.
258:
2475–2479,
1983.
|
| 97. |
Carraway, R. E., and
S. E. Leeman.
The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.
J. Biol. Chem.
248:
6854–6861,
1973.
|
| 98. |
Cascieri, M. A., and
T. Liang.
Binding of [125I] Bolton Hunter conjugated eledoisin to rat brain cortex membranes— evidence for two classes of tachykinin receptors in the mammalian central nervous system.
Life Sci.
35:
179–184,
1984.
|
| 99. |
Chahl, L. A.
Evidence that the contractile response of the guinea‐pig ileum to capsaicin is due to substance P release.
Naunyn‐Schmiedeberg's Arch. Pharmacol.
319:
212–215,
1982.
|
| 100. |
Chahl, L. A.
Substance P mediates atropine‐sensitive response of guinea‐pig ileum to serotonin.
Eur. J. Pharmacol.
87:
485–489,
1983.
|
| 101. |
Chahl, L. A.
The properties of the Clonidine withdrawal response of guinea‐pig isolated ileum.
Br. J. Pharmacol.
85:
457–462,
1985.
|
| 102. |
Chahl, L.
Effects of substance P antagonists on the atropine‐sensitive and atropine‐resistant responses of guinea‐pig ileum to substance P.
Neurosci. Lett.
55:
35–40,
1985.
|
| 103. |
Chang, K. J.
Opioid receptors: multiplicity and sequelae of ligand‐receptor interactions. In:
The Receptors,
edited by
P. M. Conn.
Orlando, FL:
Academic,
1984,
p. 1–81.
|
| 104. |
Chang, R. S. L., and
V. J.
Lorn. Biochemical and pharmacological characterization of any extremely potent and selective non‐peptide cholecystokinin antagonist.
Proc. Natl. Acad. Sci. USA
83:
4923–4926,
1986.
|
| 105. |
Chang, R. S. L.,
V. J. Lotti,
R. R. L. Monaghan,
J. Birnbaum,
E. O. Stapaley,
M. O. Goetz,
G. Albers‐Schonberg,
A. Patchett,
J. M. Liesch,
O. D. Hensens, and
J. P. Springer.
A potent non‐peptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus.
Science Wash. DC
230:
177–179,
1985.
|
| 106. |
Chan‐Palay, V.,
M. Ito,
P. Tongroach,
M. Sakurai, and
S. Palay.
Inhibitory effect of motilin, somatostatin [Leu]‐enkephalin, [Met]enkephalin and taurine on neurons of the lateral vestibular nucleus: interactions with γ‐aminobutyric acid.
Proc. Natl. Acad. Sci. USA
79:
3355–3359,
1982.
|
| 107. |
Chavkin, C., and
A. Goldstein.
Opioid receptor reserve in normal and morphine‐tolerant guinea‐pig ileum myenteric plexus.
Proc. Natl. Acad. Sci. USA
81:
7253–7257,
1984.
|
| 108. |
Chavkin, C.,
I. F. James, and
A. Goldstein.
Dynorphin is a specific endogenous ligand of the κ‐opioid receptor.
Science Wash. DC
215:
413–415,
1982.
|
| 109. |
Checler, F.,
S. Ahmad,
P. Kostka,
H. Barelli,
P. Kitabgi,
J. E. T. Fox,
C.‐Y. Kwan,
E. E. Daniel, and
J.‐P. Vincent.
Peptidases in dog ileum circular and longitudinal smooth muscle plasma membranes: their relative contribution to the metabolism of neurotensin.
Eur. J. Biochem.
166:
461–468,
1987.
|
| 110. |
Checler, F.,
H. Barelli,
C.‐Y. Kwan, and
J. P. Vincent.
Neurotensin‐metabolizing peptidases in rat fundus plasma membranes.
J. Neurochem.
49:
507–512,
1987.
|
| 111. |
Checler, F.,
F. Kostolanska, and
J. E. T. Fox.
In vivo inactivation of neurotensin in dog ileum: major involvement of endopeptidase 24.11.
J. Pharmacol. Exp. Ther.
244:
1040–1044,
1988.
|
| 112. |
Checler, F.,
J. P. Vincent, and
P. Katabgi.
Neuromedin N: high affinity interaction with brain neurotensin receptors and rapid inactivation by brain synaptosomes.
Eur. J. Pharmacol.
126:
239–244,
1986.
|
| 113. |
Cherubini, E.,
K. Morita, and
R. A. North.
Morphine augments calcium‐dependent potassium conductance in guinea‐pig myenteric neurones.
Br. J. Pharmacol.
81:
617–622,
1984.
|
| 114. |
Cherubini, E.,
K. Morita, and
R. A. North.
Opioid inhibition of synaptic transmission in the guinea‐pig myenteric plexus.
Br. J. Pharmacol.
85:
805–817,
1985.
|
| 115. |
Cherubini, E., and
R. A. North.
ä‐ and κ‐opioids inhibit transmitter release by different mechanisms.
Proc. Natl. Acad. Sci. USA
82:
1860–1863,
1985.
|
| 116. |
Chey, W. Y., and
K. Y. Lee.
Actions of motilin on gastrointestinal motility and plasma immunoreactive motilin concentration in interdigestive and postprandial states.
Endocrinol. Jpn.
1:
173–177,
1980.
|
| 117. |
Chou, C. C.,
C. P. Hsieh, and
J. M. Dabney.
Comparison of vascular effects of gastrointestinal hormones on various organs.
Am. J. Physiol.
232
(Heart Circ. Physiol. 1):
H103–H109,
1977.
|
| 118. |
Chowdhury, J. R.,
J. M. Berkowitz,
M. Praissman, and
J. W. Fara.
Interaction between octapeptide‐cholecystokinin, gastrin, and secretin on cat gallbladder in vitro.
Am. J. Physiol.
229:
1311–1315,
1975.
|
| 119. |
Chowdhury, J. R., and
S. H. Lorber.
Effects of glucagon and secretin on food and morphine‐induced motor activity of the distal colon, rectum and anal sphincter.
Am. J. Dig. Dis.
22:
775–780,
1977.
|
| 120. |
Christophe, J.,
M. Svoboda,
M. Lambert,
M. Wallbrock,
J. Winand,
J. P. Dehaze,
M. C. Wandermeers‐Piret,
A. Wandermeers, and
P. Robberecht.
Effector mechanisms of peptides of the VIP family.
Peptides Fayetteville
7,
Suppl. 1:
101–107,
1986.
|
| 121. |
Cohen, M. L., and
A. Schwab‐Landry.
Vasoactive intestinal polypeptide: increased tone, enhancement of acetylcholine release and stimulation of adenylate cyclase in intestinal smooth muscle.
Life Sci.
26:
811–822,
1980.
|
| 122. |
Cohen, M. L.,
K. S. Wiley,
E. Yaden, and
I. H. Slater.
In vitro actions of somatostatin, d‐Val1.d‐Trp8‐somatostatin and glucagon in rabbit jejunum and guinea pig ileum.
J. Pharmacol. Exp. Ther.
211:
423–429,
1979.
|
| 123. |
Cohen, S.,
W. Lipshlitz, and
W. Hughes.
Role of gastrin supersensitivity in the pathogenesis of lower esophageal sphincter hypertension in achalasia.
J. Clin. Invest.
150:
1241–1244,
1971.
|
| 124. |
Coleman, J. W.,
Q. Huang, and
D. R. Stanworth.
The mast cell response to substance P: effects of neuroaminidase, limulin, and some novel synthetic peptide antagonists.
Peptides Fayetteville
7:
171–175,
1986.
|
| 125. |
Collins, S. M.
Calcium utilization by dispersed canine gastric smooth muscle cells.
Am. J. Physiol.
251
(Gastrointest. Liver Physiol. 14):
G181–G188,
1986.
|
| 126. |
Collins, S. M., and
J. D. Gardner.
Cholecystokinin‐induced contraction of dispersed smooth muscle cells.
Am. J. Physiol.
243
(Gastrointest. Liver Physiol. 6):
G497–G504,
1982.
|
| 127. |
Collins, S. M.,
T. D. Lewis,
J. E. T. Fox,
N. S. Track,
M. M. Meghji, and
E. E. Daniel.
Changes in plasma motilin concentration in response to manipulation of intragastric and intraduodenal contents in man.
Can. J. Physiol. Pharmacol.
59:
188–194,
1981.
|
| 128. |
Connell, A. M.
The motility of the pelvic colon. II. Paradoxical motility in diarrhoea and constipation.
Gut
3:
342–349,
1962.
|
| 129. |
Connell, A. M.,
F. A. Jones, and
E. N. Rowlands.
Motility of the pelvic colon. IV. Abdominal pain associated with colonic hypermotility after meals.
Gut
6:
105–111,
1965.
|
| 130. |
Cook, M. A.,
K. Kowalewski, and
E. E. Daniel.
Electrical and mechanical activity recorded from the isolated perfused canine stomach: the effects of some GI polypeptides. In:
Proc. Fourth Int. Symp. Gastrointestinal Motility,
edited by
E. E. Daniel,
J. A. L. Gilbert,
B. Schofield,
T. K. Schnitka, and
G. Scott.
Vancouver,
Canada:
1974,
p. 233–242.
|
| 131. |
Costa, M., and
J. B. Furness.
The origins, pathways and terminations of neurons with VIP‐like immunoreactivity in the guinea‐pig small intestine.
Neuroscience
8:
665–676,
1983.
|
| 132. |
Costa, M.,
J. B. Furness,
R. Buffa, and
S. I. Said.
Distribution of enteric nerve cell bodies and axons showing immunoreactivity for vasoactive intestinal polypeptide (VIP) in the guinea‐pig intestine.
Neuroscience
5:
587–596,
1980.
|
| 133. |
Costa, M.,
J. B. Furness,
I. L. Gibbins, and
R. Murphy.
Chemical coding and projections of opioid peptide containing neurons in the guinea‐pig intestine (Abstract).
Neurosci. Lett.
S19:
S55,
1985.
|
| 134. |
Costa, M.,
J. B. Furness,
I. J. Llewellyn‐Smith, and
A. C. Cuello.
Projections of substance P‐containing nerves within the guinea‐pig small intestine.
Neuroscience
6:
411–424,
1981.
|
| 135. |
Costa, M.,
J. B. Furness,
N. Yanaihara,
C. Yanaihara, and
T. W. Moody.
Distribution and projections of neurons with immunoreactivity for both gastrin‐releasing peptide and bombesin in the guinea pig small intestine.
Cell Tissue Res.
235:
285–293,
1984.
|
| 136. |
Cotton, R.,
M. G. Giles,
L. Miller,
J. S. Shaw, and
D. Timms.
ICI 174864: a highly selective antagonist for the opioid δ‐receptor,.
Eur. J. Pharmacol.
97:
331–332,
1984.
|
| 137. |
Coupar, I. M.
Inhibition by morphine of prostaglandin‐stimulated fluid secretion in rat jejunum.
Br. J. Pharmacol.
63:
57–63,
1978.
|
| 138. |
Covineau, A.,
C. Rowyer‐Fessard,
A. Fournier,
S. St. Pierre,
R. Pipkorn, and
M. Laburthe.
Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effect of nine partial sequences.
Biochem. Biophys. Res. Commun.
121:
488–493,
1984.
|
| 139. |
Creagh, T.,
P. Skrabanek,
D. Cannon,
A. Balfe, and
D. Powell.
Phylogeny of substance P.
Gen. Comp. Endocrinol.
40:
503–506,
1980.
|
| 140. |
Creese, I., and
S. H. Snyder.
Receptor binding and pharmacological activity of opiates in the guinea‐pig intestine.
J. Pharmacol. Exp. Ther.
194:
205–219,
1975.
|
| 141. |
Crist, J.,
J. Gidda, and
R. K. Goyal.
Role of substance P nerves in longitudinal smooth muscle contractions of the esophagus.
Am. J. Physiol.
250
(Gastrointest. Liver Physiol. 13):
G336–G343,
1986.
|
| 142. |
Crochelt, R. F., and
S. R. Peikin.
Excitation‐contraction coupling in the bovine gallbladder. Measurement of 45calcium (Ca) uptake and contraction stimulated by cholecystokinin octapeptide (CCK) and potassium (K) (Abstract).
Gastroenterology
90:
1787,
1986.
|
| 143. |
Crochelt, R. F., and
S. R. Peikin.
Characterization of calcium channels mediating gallbladder contraction in the guinea pig (Abstract).
Gastroenterology
90:
1787,
1986.
|
| 144. |
Cuello, A. C.
Key address: endocrinology, oncology, tissue distribution. In:
Substance P Dublin 1983,
edited by
P. Skrabanek and
D. Powell.
Dublin:
Boole,
1983,
p. 125–128.
|
| 145. |
Dafny, N., and
N. R. Pellis.
Evidence that opiate addiction is in part an immune response. Destruction of the immune system by irradiation‐altered opiate withdrawal.
Neuropharmacology
25:
815–818,
1986.
|
| 146. |
Daniel, E. E.,
M. Costa,
J. B. Furness, and
J. R. Keast.
Peptide neurons in the canine small intestine.
J. Comp. Neurol.
237:
227–238,
1985.
|
| 147. |
Daniel, E. E.,
J. E. T. Fox,
S. M. Collins,
T. D. Lewis,
M. Meghji, and
N. S. Track.
Initiation of migrating myoelectric complexes in human subjects: role of duodenal acidification and plasma motilin.
Can. J. Physiol. Pharmacol.
59:
173–179,
1981.
|
| 148. |
Daniel, E. E.,
J. B. Furness,
M. Costa, and
L. Belbeck.
The projections of chemically identified nerve fibers in canine ileum.
Cell Tissue Res.
247:
377–384,
1987.
|
| 149. |
Daniel, E. E.,
T. Gonda,
T. Domoto,
M. Oki, and
N. Yanaihara.
The effects of substance P and Met5‐enkephalin in dog ileum.
Can. J. Physiol. Pharmacol.
60:
830–840,
1982.
|
| 150. |
Daniel, E. E.,
A. Helmy‐Elkholy,
L. P. Jager, and
M. S. Kannan.
Neither a purine nor VIP is the mediator of inhibitory nerves of opossum oesophageal smooth muscle.
J. Physiol. Lond.
336:
243–260,
1983.
|
| 151. |
Daniel, E. E.,
L. P. Jager, and
J. Jury.
Catecholamines release mediators in the opossum oesophageal circular smooth muscle.
J. Physiol. Lond.
382:
489–508,
1987.
|
| 152. |
Daniel, E. E.,
J. Jury, and
K. H. Robotham.
Receptors for neurotransmitters in opossum oesophagus muscularis mucosa.
Br. J. Pharmacol.
88:
707–714,
1986.
|
| 153. |
Daniel, E. E.,
W. H. Sutherland, and
A. Bogoch.
Effects of morphine and other drugs on the motility of the terminal ileum.
Gastroenterology
36:
510–523,
1959.
|
| 154. |
De Carle, D. J., and
M. Pye.
Is vasoactive intestinal polypeptide an inhibitory neurotransmitter in the human stomach? In:
Motility of the Digestive Tract,
edited by
M. Weinbeck.
New York:
Raven,
1982,
p. 67–72.
|
| 155. |
Delbro, D.,
L. Fändriks,
B. Lisander, and
S. A. Andersson.
Gastric atropine‐sensitive excitation by peripheral vagal stimulation after hexamethonium. Antidromic activation of afferents?
Acta Physiol. Scand.
114:
433–440,
1982.
|
| 156. |
Delbro, D.,
L. Fändriks,
S. Rosell, and
K. Folkers.
Inhibition of antidromically induced stimulation of gastric motility by substance P‐receptor blockade.
Acta Physiol. Scand.
118:
309–316,
1983.
|
| 157. |
Delbro, D., and
B. Lisander.
Non‐ganglionic cholinergic excitatory pathways in the sympathetic supply to the feline stomach. An efferent system or afferents with excitatory axon collaterals?
Acta Physiol. Scand.
110:
137–144,
1980.
|
| 158. |
Delbro, D.,
B. Lisander, and
S. A. Andersson.
Atropine‐sensitive gastric excitation by local heating—the possibility of a visceral axon reflex arrangement.
Acta Physiol. Scand.
114:
319–320,
1982.
|
| 159. |
Delbro, D.,
B. Lisander, and
S. A. Andersson.
Atropine‐sensitive gastric smooth muscle excitation by mucosal nociceptive stimulation—the involvement of an axon reflex?
Acta Physiol. Scand.
122:
621–627,
1984.
|
| 160. |
Delbro, D.,
B. Lisander, and
S. A. Andersson.
Bradykinin‐induced atropine‐sensitive gastric contractions. Activation of an intramural axon reflex?
Acta Physiol. Scand.
127:
111–117,
1986.
|
| 161. |
Dent, J.,
W. J. Dodds,
W. J. Hogan,
R. C. Arndoffer, and
B. C. Teeter.
Effect of cholecystokinin‐octapeptide on opossum lower esophageal sphincter.
Am. J. Physiol.
239
(Gastrointest. Liver Physiol. 2):
G230–G235,
1980.
|
| 162. |
Dent, J.,
W. J. Dodds,
T. Sekiguchi,
W. J. Hogan, and
R. C. Arndorfer.
Interdigestive phasic contractions of the human lower esophageal sphincter.
Gastroenterology
84:
453–460,
1983.
|
| 163. |
Dimaline, R.,
J. R. Reeve, Jr.,
J. E. Shively, and
D. Hawke.
Isolation and characterization of rat vasoactive intestinal peptide.
Peptides Fayetteville
5:
183–187,
1984.
|
| 164. |
Domoto, T.,
J. Jury,
I. Berezin,
J. E. T. Fox, and
E. E. Daniel.
Does substance P comediate with acetylcholine in nerves of opossum esophageal muscularis mucosa?
Am. J. Physiol.
245
(Gastrointest. Liver Physiol. 8):
G19–G28,
1983.
|
| 165. |
Domschke, W.
Motilin: spectrum and mode of gastrointestinal actions.
Dig. Dis. Sci.
22:
454–461,
1977.
|
| 166. |
Donnerer, J.,
L. Bartho,
P. Holzer, and
F. Lembeck.
Intestinal peristalsis associated with release of immunoreactive substance P.
Neuroscience
11:
913–918,
1984.
|
| 167. |
Donoso, M. V.,
J. P. Huidobro‐Toro, and
S. St. Pierre.
Gastrointestinal neurotensin receptors: contribution of the aromatic hydroxyl group in position 11 to peptide potency.
Br. J. Pharmacol.
87:
483–485,
1986.
|
| 168. |
Dryburgh, J. R., and
J. C. Brown.
Radioimmunoassay for motilin.
Gastroenterology
68:
1169–1176,
1975.
|
| 169. |
Dubois, A.,
P. V. Endewegh, and
J. D. Gardner.
Gastric emptying and secretion in Zollinger‐Ellison syndrome.
J. Clin. Invest.
59:
255–263,
1977.
|
| 170. |
Duchon, G.,
R. Henderson, and
E. E. Daniel.
Circular muscle layers in the small intestine.
Proc. Fourth Int. Symp. Gastrointestinal Motility,
edited by
E. E. Daniel,
J. A. L. Gilbert,
B. Schofield,
T. K. Schnitka, and
G. Scott.
Vancouver, Canada:
Mitchell,
1974,
p. 635–646.
|
| 171. |
Duranton, A., and
L. Bueno.
Central opiate mechanism involved in gastro‐intestinal motor disturbances induced by E. Coli endotoxin in sheep.
Life Sci.
31:
1975–1979,
1984.
|
| 172. |
Eckhardt, V. F., and
K. H. Holtmuller.
The effect of pentagastrin and gastrin alkalinization on lower esophageal sphincter pressure in diffuse esophageal spasm.
Digestion
13:
1–8,
1975.
|
| 173. |
Eckhardt, V. F.,
J. Kruger,
K. H. Holtmuller, and
K. Ewe.
Alteration of esophageal peristalsis by pentagastrin in patients with diffuse spasm.
Scand. J. Gastroenterol.
10:
475–479,
1975.
|
| 174. |
Edin, R.,
J. M. Lundberg,
P. Lidberg,
A. Dählstrom, and
H. Ahlman.
Atropine sensitive contractile motor effects of substance P on the feline pylorus and stomach in vivo.
Acta Physiol. Scand.
110:
207–209,
1980.
|
| 175. |
Edin R.,
J. Lundberg,
L. Terenius,
A. Dählstrom,
T. Hökfelt,
J. Kewenter, and
H. Ahlman.
Evidence for vagal enkephalinergic neural control of the feline pylorus and stomach.
Gastroenterology
78:
492–497,
1980.
|
| 176. |
Egberts, E.‐H., and
A. G. Johnson.
The effect of cholecystokinin on human taenia coli.
Digestion
15:
217–222,
1977.
|
| 177. |
Ekblad, E.,
R. Ekman,
R. Håkanson, and
F. Sundler.
GRP neurones in the rat small intestine issue long anal projections.
Regul. Pept.
9:
279–287,
1984.
|
| 178. |
Ekblad, E.,
R. Håkanson,
F. Sundler, and
C. Wahlestedt.
Galanin: neuromodulatory and direct contractile effects on smooth muscle preparations.
Br. J. Pharmacol.
86:
241–246,
1985.
|
| 179. |
Ekblad, A.,
A. Rokaeus,
R. Håkanson, and
F. Sundler.
Galanin nerve fibers in the rat gut: distribution, origin and projections.
Neuroscience
16:
355–363,
1985.
|
| 180. |
Eklund, J.,
M. Jodal,
O. Lundgren, and
A. Sjoquist.
Effects of vasoactive intestinal polypeptide on blood flow, motility and fluid transport in the gastrointestinal tract of the cat.
Acta Physiol. Scand.
105:
461–468,
1979.
|
| 181. |
El‐Sharkawy, T. Y., and
J. H. Szurszewski.
Modulation of canine antral circular smooth muscle by acetylcholine, noradrenaline and pentagastrin.
J. Physiol. Lond.
279:
309–320,
1978.
|
| 182. |
Erspamer, V.
Peptides of the amphibian skin active in the gut. II. Bombesin‐like peptides: isolation, structure and basic function. In:
Gastrointestinal Hormones,
edited by
G. B. Jerzy Glass,
New York:
Raven,
1980,
p. 343–361.
|
| 183. |
Erspamer, V.
The tachykinin peptide family.
Trends Neurosci.
4:
267–269,
1981.
|
| 184. |
Escher, E.,
P. D'Orleans‐Juste,
S. Dion,
G. Drapeau,
J. Mizrahi, and
D. Regoli.
A substance P antagonist not containing d‐tryptophan.
Eur. J. Pharmacol.
105:
375–377,
1984.
|
| 185. |
Evans, B. E.,
M. G. Bock,
K. E. Rittle,
R. M. DiPardo,
W. L. Whitter,
D. F. Veber,
P. S. Anderson, and
R. M. Freidinger.
Design of potent, orally effective nonpeptide antagonists of the peptide hormone, cholecystokinin.
Proc. Natl. Acad. Sci. USA
83:
4918–4922,
1986.
|
| 186. |
Fahrenkrug, J.,
T. Bek,
J. M. Lundberg, and
T. Hökfelt.
VIP and PHI in cat neurons: co‐localization but variable tissue content possibly due to differential processing.
Regul. Pept.
12:
21–34,
1985.
|
| 187. |
Fahrenkrug, J.,
H. Galbo,
J. J. Holst, and
O. B. Schaffalitzky de Muckadell.
Influence of the autonomic nervous system on the release of vasoactive intestinal polypeptide from the porcine gastrointestinal tract.
J. Physiol. Lond.
280:
405–422,
1978.
|
| 188. |
Fändricks, L., and
D. Delbro.
Neural stimulation of gastric bicarbonate secretion in the cat. An involvement of axon‐reflexes and substance P?
Acta Physiol. Scand.
118:
301–304,
1983.
|
| 189. |
Fändricks, L., and
D. Delbro.
Non‐nicotinic, non‐adrenergic excitatory motor fibers in the preganglionic sympathetic supply to the feline colon. An axon reflex arrangement associated to thin sensory neurons, involving substance P?
Acta Physiol. Scand.
123:
273–284,
1985.
|
| 190. |
Fara, J. W.,
M. Praissman, and
J. M. Berkowitz.
Interaction between gastrin CCK and secretin on canine antral smooth muscle in vitro.
Am. J. Physiol. (Endocrinol. Metab. Gastrointest. Physiol.
5):
E39–E44,
1979.
|
| 191. |
Featherstone, R. L.,
P. Fosbraey, and
I. K. Morton.
A comparison of the effects of three substance P antagonists on tachykinin‐stimulated [3H]‐acetylcholine release in the guinea‐pig ileum.
Br. J. Pharmacol.
87:
73–78,
1986.
|
| 192. |
Ferre, J. P.,
C. Du,
G. Soldani, and
Y. Ruckebusch.
Peripheral versus central components of the effects of der‐morphin on intestinal motility in the fed rat.
Regul. Pept.
13:
109–117,
1986.
|
| 193. |
Fioramonti, J.,
L. Bueno, and
M. J. Fargeas.
Enhancement of colonic motor response to feeding by central endogenous opiates in the dog.
Life Sci.
36:
2509–2514,
1985.
|
| 194. |
Fioramonti, J.,
M. J. Fargeas, and
L. Bueno.
The involvement of opiate receptors in the effects of trimebutine on intestinal motility in the conscious dog.
J. Pharm. Pharmacol.
36:
618–621,
1984.
|
| 195. |
Fioramonti, J.,
M. J. Fargeas, and
L. Bueno.
Comparative effects of morphine and cyclazocine on gastrointestinal motility in conscious dogs.
Arch. Int. Pharmacodyn. Ther.
270:
141–150,
1982.
|
| 196. |
Fisher, R. S.,
A. J. Dimarino, and
S. Cohen.
Mechanisms of cholecystokinin inhibition of lower esophageal sphincter pressure.
Am. J. Physiol.
228:
1469–1473,
1975.
|
| 197. |
Forssmann, V. G.,
N. Yanaihara,
V. Helmstaedter, and
D. Grube.
Differential demonstration of the motilin‐cell and the enterochromaffin‐cell.
Scand. J. Gastroenterol.
11:
43–45,
1976.
|
| 198. |
Fosbraey, P.,
R. L. Featherstone, and
I. K. M. Morton.
Comparison of potency of substance P and related peptides on [3H]‐acetylcholine release, and contractile actions, in the guinea‐pig ileum.
Naunyn‐Schmiedeberg's Arch. Pharmacol.
326:
111–115,
1984.
|
| 199. |
Fosbraey, P., and
E. S. Johnson.
Release‐modulating acetylcholine receptors in cholinergic neurones of the guinea pig ileum.
Br. J. Pharmacol.
68:
289–300,
1980.
|
| 200. |
Fournier, A.,
J. K. Saunders, and
S. St. Pierre.
Synthesis, conformational studies and biological activities of VIP and related fragments.
Peptides Fayetteville
5:
169–177,
1984.
|
| 201. |
Fox, J. E. T.
Motilin—An update.
Life Sci.
35:
695–706,
1984.
|
| 202. |
Fox, J. E. T.,
S. M. Collins, and
E. E. Daniel.
Expression of peptide responses depends upon study environment. In:
Regulatory Peptides in Digestive, Nervous and Endocrine Systems,
edited by
M. J. M. Lewin and
S. Bonfils.
Amsterdam:
Elsevier,
1985,
p. 265–268.
|
| 203. |
Fox, J. E. T., and
E. E. Daniel.
Substance P: a potent inhibitor of the canine small intestine in vivo.
Am. J. Physiol.
250
(Gastrointest. Liver Physiol. 13):
G21–G27,
1986.
|
| 204. |
Fox, J. E. T., and
E. E. Daniel.
Exogenous opiates: their local mechanisms of action in the canine small intestine and stomach.
Am. J. Physiol.
253
(Gastrointest. Liver Physiol. 16):
G179–G188,
1987.
|
| 205. |
Fox, J. E. T., and
E. E. Daniel.
Activation of endogenous excitatory opiate pathways in the canine small intestine by field stimulation and motilin.
Am. J. Physiol.
253
(Gastrointest. Liver Physiol. 16):
G189–G194,
1987.
|
| 206. |
Fox, J. E. T.,
E. E. Daniel,
J. Jury,
A. E. Fox, and
S. Collins.
Sites and mechanisms of action of neuropeptides on canine gastric motility differ in vivo and in vitro.
Life Sci.
33:
817–825,
1983.
|
| 207. |
Fox, J. E. T.,
E. E. Daniel,
J. Jury, and
H. Robotham.
The mechanism of motilin excitation in canine small intestine.
Life Sci.
34:
1001–1006,
1984.
|
| 208. |
Fox, J. E. T.,
E. E. Daniel,
J. Jury,
N. S. Track, and
S. Chiu.
Colinergic control mechanisms for immunoreactive motilin release and motility in the canine duodenum.
Can. J. Physiol. Pharmacol.
61:
1042–1049,
1983.
|
| 209. |
Fox, J. E. T.,
F. Kostolanska,
E. E. Daniel,
H. D. Allescher, and
T. Hanke.
Mechanism of excitatory actions of neurotensin on canine small intestinal circular muscle in vivo and in vitro.
Can. J. Physiol. Pharmacol.
65:
2254–2259,
1987.
|
| 210. |
Fox, J. E. T., and
T. J. McDonald.
Motor effects of gastrin releasing peptide (GRP) and bombesin in the canine stomach and small intestine.
Life Sci.
35:
1667–1673,
1984.
|
| 211. |
Fox, J. E. T.,
T. J. McDonald,
L. Alford, and
F. Kostolanska.
Tachykinin activation of muscarinic inhibition in canine small intestine is SPP in nature.
Life Sci.
39:
1123–1128,
1986.
|
| 212. |
Fox, J. E. T.,
T. J. McDonald,
F. Kostolanska, and
K. Tatemoto.
Galanin: an inhibitory neural peptide in the canine small intestine.
Life Sci.
39:
103–110,
1986.
|
| 213. |
Fox, J. E. T.,
N. S. Track, and
E. E. Daniel.
Motilin: its presence and function in muscle layers of the gastrointestinal tract.
Gastrointestinal Motility,
edited by
J. Christenson,
New York:
Raven,
1980,
p. 59–65.
|
| 214. |
Fox, J. E. T.,
N. S. Track, and
E. E. Daniel.
Relationship of plasma motilin concentration to fat ingestion, duodenal acidification and alkalization, and migrating motor complexes in dogs.
Can. J. Physiol. Pharmacol.
59:
180–187,
1981.
|
| 215. |
Fox, J. E. T.,
N. S. Track,
E. E. Daniel, and
N. Yanaihara.
Immunoreactive motilin is not exclusive to the gastrointestinal mucosa.
Biomed. Res.
2:
321–324,
1981.
|
| 216. |
Fox‐Robichaud, A. E., and
S. M. Collins.
Altered calcium handling properties of jejunal muscle from Nippostrongylus brasiliensis infected rats.
Gastroenterology
91:
1462–1469,
1986.
|
| 217. |
Franco, R.,
M. Costa, and
J. B. Furness.
Evidence for the release of endogenous substance P from intestinal nerves.
Naunyn‐Schmiedeberg's Arch. Pharmacol.
306:
195–201,
1979.
|
| 218. |
Fujisawa, K., and
Y. Ito.
The effects of substance P on smooth muscle cells and on neuro‐effector transmission in the guinea‐pig ileum.
Br. J. Pharmacol.
76:
279–290,
1982.
|
| 219. |
Furness, J. B., and
M. Costa.
Action of somatostatin on excitatory and inhibitory nerves in the intestine.
Eur. J. Pharmacol.
56:
69–74,
1979.
|
| 220. |
Furness, J. B., and
M. Costa.
Identification of gastrointestinal neurotransmitters. In:
Mediators and Drugs in Gastrointestinal Motility. Morphological Basis and Neurophysiological Control,
edited by
G. Bertaccini.
New York:
Springer‐Verlag,
1982,
vol. 1,
p. 384–462.
|
| 221. |
Furness, J. B.,
M. Costa,
I. J. Llewellyn‐Smith,
J. R. Keast,
J. C. Bornstein,
R. Murphy, and
I. L. Gibbins.
Regulatory peptides of gastrointestinal hormones. In:
Regulatory Peptides in Digestive, Nervous Endocrine Systems,
edited by
M. J. M. Lewin and
S. Bonfils.
Amsterdam:
Elsevier,
1985,
p. 219–226.
|
| 222. |
Gaion, R. M., and
M. Trento.
The role of adrenergic, purinergic and opiate receptors in the control of prostacyclin‐induced contraction in the guinea‐pig ileum.
Arch. Int. Pharmacodyn. Ther.
271:
33–44,
1984.
|
| 223. |
Gallican, J. J., and
T. F. Burks.
Opioid peptides inhibit intestinal transit in the rat by a central mechanism.
Eur. J. Pharmacol.
85:
61–68,
1982.
|
| 224. |
Gardner, J. D., and
R. T. Jensen.
Receptor for secretagogues on pancreatic acinar cells.
Am. J. Physiol.
238
(Gastrointest. Liver Physiol.):
G63–G66,
1980.
|
| 225. |
Garrett, J. M.
Colonic motility in ulcerative colitis after opiate administration.
Gastroenterology
53:
93–100,
1967.
|
| 226. |
Garrick, T.,
S. Buack, and
P. Bass.
Gastric motility is a major factor in cold restraint‐induced lesion formation in rats.
Am. J. Physiol.
250
(Gastrointest. Liver Physiol. 13):
G191–G199,
1986.
|
| 227. |
Garzon, J.,
R. Schultz, and
A. Herz.
Evidence for the ɛ‐type of opioid receptor in the rat vas deferens.
Mol. Pharmacol.
28:
1–9,
1985.
|
| 228. |
Gerner, T.
Pressure responses of OP‐CCK compared to CCK‐P2 in the antrum and fundus of isolated guinea pig stomachs.
Scand. J. Gastroenterol.
14:
73–77,
1979.
|
| 229. |
Gerner, T., and
J. F. W. Haffner.
The role of local cholinergic pathways in the motor response to cholecystokinin and gastrin in isolated guinea pig fundus and antrum.
Scand. J. Gastroenterol.
12:
751–757,
1977.
|
| 230. |
Gerner, T.,
J. F. W. Haffner, and
J. Norstein.
The effects of mepyramine and cimetidine on the motor responses to histamine, cholecystokinin and gastrin in the fundus and antrum of isolated guinea pig stomachs.
Scand. J. Gastroenterol.
14:
65–72,
1979.
|
| 231. |
Gillan, M. G. C., and
D. Pollock.
Acute effects of morphine and opioid peptides on the motility and responses of rat colon to electrical stimulation.
Br. J. Pharmacol.
68:
381–392,
1980.
|
| 232. |
Gintzler, A. R.
Serotonin participation in gut withdrawal from opiates.
J. Pharmacol. Exp. Ther.
211:
7–12,
1979.
|
| 233. |
Gintzler, A. R.
Substance P involvement in the expression of gut dependence on opiates.
Brain Res.
182:
224–228,
1980.
|
| 234. |
Gintzler, A. R., and
D. Hyde.
Multiple opiate receptors in the guinea‐pig enteric nervous system: unmasking the copresence of receptor subtypes.
Proc. Natl. Acad. Sci. USA
81:
2252–2254,
1984.
|
| 235. |
Gintzler, A. R., and
J. A. Scalisi.
Physiological correlates of multiple subtypes of enteric opiate receptor; functional analysis of myenteric δ‐receptors.
Brain Res.
238:
254–259,
1982.
|
| 236. |
Gintzler, A. R., and
J. A. Scalisi.
Effects of opioids on noncholinergic excitatory responses of the guinea‐pig isolated ileum: inhibition of release of enteric substance P.
Br. J. Pharmacol.
75:
199–205,
1982.
|
| 237. |
Girod, C.,
N. Durand, and
J. L. Gourru.
Immunocytochemical identification of bombesin‐like peptide containing cells in the gastrointestinal tract of the monkey, Macaca rhesus.
Biomed. Res.
3:
252–260,
1982.
|
| 238. |
Glasel, J. A.,
W. M. Bradbury, and
R. F. Venn.
Opiate binding to subcellular fractions from guinea pig‐ileum.
Life Sci.
34:
343–351,
1984.
|
| 239. |
Goedert, M.,
J. C. Hunter, and
M. Ninkovic.
Evidence for neurotensin as a non‐cholinergic, non‐adrenergic neurotransmitter in guinea pig ileum.
Nature Lond.
311:
59–62,
1984.
|
| 240. |
Goldstein, A., and
I. F. James.
Multiple opioid receptors: criteria for identification and classification.
Trends Pharmacol. Sci.
5:
503–505,
1984.
|
| 241. |
Goodman, E. C., and
L. L. Iversen.
Calcitonin gene‐related peptide: novel neuropeptide.
Life Sci.
38:
2169–2178,
1986.
|
| 242. |
Goyal, R. K., and
S. Rattan.
VIP as a possible neurotransmitter of non‐cholinergic non‐adrenergic inhibitory neurones.
Nature Lond.
288:
378–380,
1980.
|
| 243. |
Gozes, I.,
M. Bodner,
Y. Shani, and
M. Fridkin.
Structure and expression of the vasoactive intestinal peptide (VIP) gene in a human tumour.
Peptides Fayetteville
7,
Suppl. 1:
1–6,
1986.
|
| 244. |
Gregory, R. A.
The isolation and chemistry of gastrin.
Gastroenterobgy
51:
953–959,
1966.
|
| 245. |
Gregory, R. A., and
H. J. Tracy.
The constitution and properties of two gastrins extracted from hog antral mucosa.
Gut
5:
103–117,
1964.
|
| 246. |
Grider, J. R.,
M. B. Cable,
K. N. Bitar,
S. I. Said, and
G. M. Makhlouf.
Vasoactive intestinal peptide relaxant neurotransmitter in taenia coli of the guinea pig.
Gastroenterology
89:
36–42,
1985.
|
| 247. |
Grider, J. R.,
M. B. Cable,
S. I. Said, and
G. M. Makhlouf.
Vasoactive intestinal peptide as a neural mediator of gastric relaxation.
Am. J. Physiol.
248
(Gastrointest. Liver Physiol. 11):
G73–G78,
1985.
|
| 248. |
Grider, J. R.,
C. J. Loewe, and
G. M. Makhlouf.
Characterization of myoreceptors and neuroreceptors for CCK in the gut with the CCK/gastrin receptor antagonist proglumide.
Gastroenterology.
In press.
|
| 249. |
Grider, J. R., and
G. M. Makhlouf.
Colonic peristaltic reflex: identification of vasoactive intestinal peptide as mediator of descending relaxation.
Am. J. Physiol.
251
(Gastrointest. Liver Physiol. 14):
G40–G45,
1986.
|
| 250. |
Grönstad, K.,
H. Ahlman,
A. Dahlström,
B. M. Jaffe,
P. Lidberg, and
M. J. Zinner.
The effects of vagal nerve stimulation on the levels of serotonin and substance P in the portal vein of the cat.
Biogenic Amines
1:
303–311,
1984.
|
| 251. |
Grossman, M. I.
Gastrin, cholecystokinin and secretin act on one receptor.
Lancet
1:
1088–1089,
1970.
|
| 252. |
Grovum, W. L., and
H. W. Chapman.
Pentagastrin in the circulation acts directly on the brain to depress motility of the stomach in sheep.
Regul. Pept.
5:
35–42,
1982.
|
| 253. |
Guillemin, R.
Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus.
Endocrinology
99:
1653–1654,
1976.
|
| 254. |
Håkanson, R.,
J. Hörig, and
S. Leander.
The mechanism of action of a substance P antagonist (d‐Pro2, d‐Trp7,9)‐SP.
Br. J. Pharmacol.
77:
697–700,
1982.
|
| 255. |
Hall, K. E.,
N. E. Diamant,
T. Y. El‐Sharkawy, and
G. R. Greenberg.
Effect of pancreatic polypeptide on canine migrating motor complex and plasma motilin.
Am. J. Physiol.
245
(Gastrointest. Liver Physiol. 8):
G178–G185,
1983.
|
| 256. |
Hall, M. E., and
J. M. Stewart.
Substance P and behaviour: Opposite effects of N‐terminal and C‐terminal fragments.
Peptides Fayetteville
4:
763–768,
1983.
|
| 257. |
Hammer, R. A.,
R. E. Carraway, and
S. E. Leeman.
Elevation of plasma neurotensin‐like immunoreactivity after a meal. Characterization of the elevated components.
J. Clin. Invest.
70:
74–81,
1982.
|
| 258. |
Hammer, R. A.,
S. E. Leeman,
R. Carraway, and
R. H. Williams.
Isolation of human intestinal neurotensin.
J. Biol. Chem.
255:
2476–2480,
1980.
|
| 259. |
Hara, Y.,
M. Kubota, and
J. Szurszewski.
Electrophysiology of smooth muscle of the small intestine of some mammals.
J. Physiol. Lond.
372:
501–520,
1986.
|
| 260. |
Hara, Y., and
J. Szurszewski.
Effect of potassium and acetylcholine on canine intestinal smooth muscle.
J. Physiol. Lond.
372:
521–537,
1986.
|
| 261. |
Harvey, R. F., and
A. E. Read.
Effect of cholecystokinin on colonic motility and symptoms in patients with irritable bowel syndrome.
Lancet
1:
1–3,
1973.
|
| 262. |
Hawcock, A. B.,
A. G. Hayes, and
M. B. Tyers.
Agonist effects of [d‐Pro2,d‐Phe7,d‐Trp9]substance P—evidence for different receptors.
Eur. J. Pharmacol.
80:
135–138,
1982.
|
| 263. |
Hayakawa, Y.,
K. I. Obata,
N. Itoh,
N. Yanaihara, and
H. Okamoto.
Cyclic AMP regulation of pro‐vasoactive intestinal polypeptide/PHM‐27 synthesis in human neuroblastoma cells.
J. Biol. Chem.
259:
9207–9211,
1984.
|
| 264. |
Hayashi, H.,
K. Ohsumi,
M. Fujiwara,
N. Mizuno,
I. Kanazawa, and
H. Yajima.
Immunohistochemical studies on enteric substance P of extrinsic origin in the cat.
J. Auton. Nerv. Sys.
5:
207–217,
1982.
|
| 265. |
Hayashi, H.,
K. Ohsumi,
N. Ueda,
M. Fujiwara, and
N. Mizuno.
Effect of spinal ganglionectomy on substance P‐like immunoreactivity in the gastroduodenal tract of cats.
Brain Res.
232:
227–230,
1982.
|
| 266. |
Hays, S. E.,
M. C. Beinfeld,
R. T. Jensen,
F. K. Goodwin, and
S. M. Paul.
Demonstration of a putative receptor site for cholecystokinin in rat brain.
Neuropeptides
1:
53–62,
1980.
|
| 267. |
Hedner, P.
Effect of the C‐terminal octapeptide of cholecystokinin on guinea pig ileum and gallbladder in vitro.
Acta Physiol. Scand.
78:
232–235,
1970.
|
| 268. |
Hedner, P.,
H. Persson, and
G. Rorsman.
Effect of cholecystokinin on small intestine.
Acta Physiol. Scand.
70:
250–254,
1967.
|
| 269. |
Heitz, P. U.,
M. Kasper,
G. Krey,
J. M. Polak, and
A. G. E. Pearse.
Immunoelectron cytochemical localization of motilin in human duodenal enterochromaffin cells.
Gastroenterology
74:
713–718,
1978.
|
| 270. |
Helmstaedter, V.,
W. Krepplin,
W. Domschke,
P. Mitznegg,
N. Yanaihara,
E. Wunsch, and
W. G. Forssmann.
Immunohistochemical localization of motilin in endocrine non‐enterochromaffin cells of the small intestine of humans and monkey.
Gastroenterology
76:
897–902,
1979.
|
| 271. |
Helström, P. M.
Pharmacological analysis of the mechanism of action for colonic contraction induced by neurotensin, substance P and methionine‐enkephalin.
Acta Physiol. Scand.
125:
13–24,
1985.
|
| 272. |
Helström, P. M., and
S. Rosell.
Effect of neurotensin, substance P and methionine‐enkephalin on colonic motility.
Acta Physiol. Scand.
113:
147–154,
1981.
|
| 273. |
Herbert, E.,
E. Oates,
G. Martens,
M. Comb,
H. Rosen, and
M. Uhler.
Generation of diversity and evolution of opioid peptides.
Cold Spring Harbour Symp. Quant. Biol.
48:
375–384,
1983.
|
| 274. |
Hersch, L. B.
Nomenclature and classification of enkephalin‐degrading peptidases.
Trends Pharmacol. Sci.
7:
346–347,
1986.
|
| 275. |
Hirning, L. D.,
F. Porreca, and
T. F. Burks,
But not κ, opioid agonists induce contractions of the canine small intestine ex vivo.
Eur. J. Pharmacol.
109:
49–54,
1985.
|
| 276. |
Hirst, G. D. S.,
M. E. Holman, and
I. Spence.
Two types of neurones in the myenteric plexus of the duodenum of the guinea pig.
J. Physiol. Lond.
236:
303–326,
1974.
|
| 277. |
Hogan, W. J.,
W. J. Dodds, and
J. E. Geenan.
The biliary tract. In:
A Guide to Gastrointestinal Motility,
edited by
J. Christensen,
D. L. Wingate, and
R. A. Gregory.
Bristol, UK:
Wright,
1983,
p. 157–197.
|
| 278. |
Holloway, R. H.,
E. Blank,
I. Takahashi,
W. J. Dodds, and
R. D. Layman.
Motilin: a mechanism incorporating the opossum lower esophageal sphincter into the migrating motor complex.
Gastroenterology
89:
507–515,
1985.
|
| 279. |
Holmgren, S.
The effects of putative non‐adrenergic, non‐cholinergic autonomic transmitters on isolated strips from the stomach of the rainbow trout, Salmo gairdneri.
Comp. Biochem. Physiol.
74C:
229–238,
1983.
|
| 280. |
Holmgren, S.,
D. J. Grove, and
S. Nilsson.
Substance P acts by releasing 5‐hydroxytryptamine from enteric neurons in the stomach of the rainbow trout, Salmo gairdneri.
Neuroscience
14:
683–693,
1985.
|
| 281. |
Holmgren, S.,
J. Jensen,
A. C. Jonsson,
K. Lundin, and
S. Nilsson.
Neuropeptides in the gastrointestinal canal of Necturus maculosus.
Cell Tissue Res.
241:
565–580,
1985.
|
| 282. |
Holmgren, S.,
C. Vaillant, and
R. Dimaline.
VIP‐, substance P‐, gastrin/CCK‐, bombesin‐, somatostatin‐ and glucagon‐like immunoreactivities in the gut of the rainbow trout, Salmo gairdneri.
Cell Tissue Res.
223:
141–153,
1982.
|
| 283. |
Holzer, P.
An enquiry into the mechanism by which substance P facilitates the phasic longitudinal contractions of the rabbit ileum.
J. Physiol. Lond.
325:
377–392,
1982.
|
| 284. |
Holzer, P., and
F. Lembeck.
Longitudinal contraction of isolated guinea‐pig ileum induced by rapid cooling.
Naunyn‐Schmiedeberg's Arch. Pharmacol.
310:
169–174,
1979.
|
| 285. |
Holzer, P., and
F. Lembeck.
Neurally mediated contraction of ileal longitudinal muscle by substance P.
Neurosci. Lett.
17:
101–105,
1980.
|
| 286. |
Holzer, P. and
I. T. Lippe.
Substance P actions on phosphoinositides in guinea‐pig intestinal muscle: a possible transduction mechanism?
Naunyn Schmiedeberg's Arch. Pharmacol.
329:
50–55,
1985.
|
| 287. |
Holzer, P., and
U. Petsche.
On the mechanism of contraction and desensitization induced by substance P in the intestinal muscle of the guinea‐pig.
J. Physiol. Lond.
342:
549–568,
1983.
|
| 288. |
Holzer, P.,
U. Petsche, and
I. T. Lippe.
A study of the mechanisms which underlie the contractile effect of substance P on intestinal smooth muscle. In:
Substance P Dublin 1983,
edited by
P. Skrabanek and
D. Powell.
Dublin:
Boole,
1983,
p. 92–93.
|
| 289. |
Holzer, P., and
W. Sametz.
Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin‐sensitive afferent neurons.
Gastroenterology
91:
975–981,
1986.
|
| 290. |
Honeyman, T.,
P. Merriam, and
F. S. Fay.
The effect of isoproterenol on adenosine cyclic 3′,5′‐monophosphate and contractility in isolated smooth muscle cells.
Mol. Pharmacol.
14:
86–98,
1978.
|
| 291. |
Hostein, J.,
J. Janssens,
G. Vantrappen,
T. L. Peeters,
M. Vandeweerd, and
G. Reman.
Somatostatin induces ectopic activity fronts of the migrating motor complex via a local intestinal mechanism.
Gastroenterology
87:
1004–1008,
1984.
|
| 292. |
Hua, X.‐Y.
Tachykinins and calcitonin gene‐related peptide in relation to peripheral functions of capsaicin‐sensitive sensory neurons.
Acta Physiol. Scand. Suppl.
551:
1–45,
1986.
|
| 293. |
Hughes, S.,
N. B. Higgs, and
L. A. Turnberg.
Loperamide has antisecretatory activity in the human jejunum in vivo.
Gut
25:
931–935,
1984.
|
| 294. |
Huidobro‐Toro, J. P.
Non‐neuronal excitatory neurotensin receptors on the taenia coli of the guinea pig: lack of influence of tetrodotoxin and dynorphin.
Neurosci. Lett.
38:
390–314,
1983.
|
| 295. |
Huidobro‐Toro, J. P., and
A. Kullak.
Excitatory neurotensin receptors on the smooth muscle of the rat fundus: possible implications in gastric motility.
Br. J. Pharmacol.
84:
897–910,
1985.
|
| 296. |
Huidobro‐Toro, J. P., and
E. L. Way.
Contractile effects of morphine and related opioid alkaloids, β‐endorphin and methionine enkephalin on the isolated colon from Long Evans rats.
Br. J. Pharmacol.
74:
681–694,
1981.
|
| 297. |
Huidobro‐Toro, J. P.,
Y.‐X. Zhu,
N. M. Lee,
H. H. Loh, and
E. L. Way.
Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
J. Pharmacol. Exp. Ther.
228:
293–303,
1984.
|
| 298. |
Huizinga, J. D.,
G. Chang,
N. E. Diamant, and
T. Y. El‐Sharkawy.
The effects of cholecystokinin octapeptide and pentagastrin on electrical and motor activities of canine colonic circular muscle.
Can. J. Physiol. Pharmacol.
62:
1440–1447,
1984.
|
| 299. |
Huizinga, J. D.,
G. Chang,
N. E. Diamant, and
T. Y. El‐Sharkawy.
Electrophysiological basis of excitation of canine colonic circular muscle by cholinergic agents and substance P.
J. Pharmacol. Exp. Ther.
231:
692–699,
1984.
|
| 300. |
Hunter, J. C.,
M. Goedert, and
R. D. Pinnock.
Mammalian tachykinin‐induced hydrolysis of inositol phospholipids in rat brain slices.
Biochem. Biophys. Res. Commun.
15:
616–622,
1985.
|
| 301. |
Hutchison, J. B., and
G. J. Dockray.
Evidence that the action of cholecystokinin octapeptide on the guinea pig ileum longitudinal muscle is mediated in part by Substance P release from the myenteric plexus.
Eur. J. Pharmacol.
69:
87–91,
1981.
|
| 302. |
Innis, R. B., and
S. H. Snyder.
Distinct cholecystokinin receptors in brain and pancreas.
Proc. Natl. Acad. Sci. USA
77:
6917–6921,
1980.
|
| 303. |
Isenberg, J. I., and
A. Csendes.
Effect of octapeptide of cholecystokinin on canine pyloric pressure.
Am. J. Physiol.
222:
428–431,
1972.
|
| 304. |
Ishii, T., and
Y. Shimo.
Nerve‐mediated non‐adrenergic inhibitory responses of guinea‐pig taenia caeci: further evidence of depression by morphine.
J. Pharm. Pharmacol.
35:
838–830,
1983.
|
| 305. |
Ito, S.,
T. Ohta,
Y. Nakazato,
A. Ohga, and
N. Yanaihara.
Effects of avian pancreatic peptide on smooth muscle relaxations by vasoactive intestinal peptide and inhibitory nerve stimulation.
Jpn. J. Pharmacol.
40:
423–434,
1986.
|
| 306. |
Itoh, N.,
K. I. Obata,
N. Yanaihara, and
H. Okamoto.
Human preprovasoactive intestinal polypeptide contains a novel PHI‐27‐like peptide, PHM‐27.
Nature Lond.
304:
547–549,
1983.
|
| 307. |
Jacobowitz, D. M.,
T. L. O'Donohue,
W. Y. Chey, and
T. Chang.
Mapping of motilin‐immunoreactive neurons of the rat brain.
Peptides Fayetteville
2:
479–487,
1981.
|
| 308. |
Jacoby, H. I.,
I. Lopez,
D. Wright, and
J. L. Vaught.
Differentiation of multiple neurokinin receptors in the guinea pig ileum.
Life Sci.
39:
1995–2003,
1986.
|
| 309. |
Jacoby, H. I., and
C. H. Marshall.
Gastric motor‐stimulating activity of gastrin‐tetrapeptide in dogs.
Gastroenterology
56:
80–87,
1969.
|
| 310. |
Jaffe, J. H., and
W. R. Martin.
Opioid analgesics and antagonists. In:
Goodman and Gilman's The Pharmacological Basis of Therapeutics
(7th ed.),
edited by
A. G. Gilman,
L. S. Goodman,
T. W. Rail, and
F. Murad.
New York:
Macmillan,
1985,
p. 491–531.
|
| 311. |
James, I. F.,
W. Fischli, and
A. Goldstein.
Opioid receptor selectivity of dynorphin gene products.
J. Pharmacol. Exp. Ther.
228:
88–93,
1984.
|
| 312. |
Janssens, J.,
G. Vantrappen and
T. L. Peeters.
The activity front of the migrating motor complex of the human stomach but not of the small intestine is motilin dependent.
Regul. Pept.
6:
363–369,
1983.
|
| 313. |
Jennewein, H. M.,
R. Bauer, and
H. Hummelt.
Motilin effects on gastrointestinal motility and lower esophageal sphincter (LES) pressure in dogs.
Scand. J. Gastroenterol.
11:
63–65,
1976.
|
| 314. |
Jensen, R. T.,
S. W. Jones,
K. Folkers, and
J. D. Gardner.
A synthetic peptide that is a bombesin antagonist.
Nature Lond.
309:
61–63,
1984.
|
| 315. |
Jensen, R. T.,
G. F. Lemp, and
J. D. Gardner.
Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells.
Proc. Natl. Acad. Sci. USA
77:
2079–2083,
1980.
|
| 316. |
Jensen, R. T.,
T. Moody,
C. Pert,
J. E. Rivier, and
J. D. Gardner.
Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells.
Proc. Natl. Acad. Sci. USA
75:
6139–6143,
1978.
|
| 317. |
Jensen, R. T.,
Z.‐C. Zhou,
R. B. Murphy,
S. W. Jones,
I. Setnikar,
L. A. Rovati, and
J. D. Gardner.
Structural features of various proglumide‐related cholecystokinin receptor antagonists.
Am. J. Physiol.
251
(Gastrointest. Liver Physiol. 14):
G839–G846,
1986.
|
| 318. |
Jivegard, L.,
E. Thornell,
S. Bjorck, and
J. Svanvik.
The effects of morphine and enkephalin on gallbladder function in experimental cholecystitis.
Scand. J. Gastroenterol.
20:
1049–1056,
1985.
|
| 319. |
Johnson, E. E.
Morphine: a dual effect at the canine choledochoduodenal junction.
J. Pharmacol. Exp. Ther.
219:
274–280,
1981.
|
| 320. |
Johnson, L. R., and
M. Grossman.
Analysis of inhibition of acid secretion by cholecystokinin in dogs.
Am. J. Physiol.
218:
550–554,
1970.
|
| 321. |
Johnson, S. M.,
Y. Katayama,
K. Morita, and
R. A. North.
Mediators of slow synaptic potentials in the myenteric plexus of the guinea‐pig ileum.
J. Physiol. Lond.
320:
175–186,
1981.
|
| 322. |
Johnson, S. M.,
Y. Katayama, and
R. A. North.
Slow synaptic potentials in neurones of the myenteric plexus.
J. Physiol. Lond.
301:
505–516,
1980.
|
| 323. |
Jorpes, J. E.
The isolation and chemistry of secretin and cholecystokinin.
Gastroenterology
55:
157–164,
1968.
|
| 324. |
Jurna, I., and
G. Zetler.
Antinociceptive effect of centrally administered caerulein and cholecystokinin octapeptide.
Eur. J. Pharmacol.
73:
323–331,
1981.
|
| 325. |
Jury, J.,
L. P. Jager, and
E. E. Daniel.
Unusual potassium channels mediate non‐adrenergic non‐cholinergic nerve mediated inhibition in opossum esophagus.
Can. J. Physiol. Pharmacol.
63:
107–112,
1985.
|
| 326. |
Kachel, G. W.,
L. L. Frase,
W. Domschke,
W. Y. Chey, and
G. J. Krejs.
Effect of 13‐norleucine‐motilin on water and ion transport in the human jejunum.
Gastroenterology
87:
550–556,
1984.
|
| 327. |
Kachel, G. W.,
H. Ruppin,
J. Hagel,
W. Barina,
M. Meinhardt, and
W. Domschke.
Human intestinal motor activity and transport: effects of a synthetic opiate.
Gastroenterology
90:
85–93,
1986.
|
| 328. |
Kachelhoffer, J.,
C. Mendel,
J. Danchel,
D. Hohmatteo, and
J. F. Grenier.
The effects of VIP on intestinal motility: study on ex vivo perfused isolated canine jejunal loops.
Dig. Dis. Sci.
21:
957–962,
1976.
|
| 329. |
Kachur, J. F., and
R. J. Miller.
Characterization of the opiate receptor in the guinea‐pig ileal mucosa.
Eur. J. Pharmacol.
81:
177–183,
1982.
|
| 330. |
Kamikawa, Y., and
Y. Shimo.
Pharmacological characterization of the opioid receptor in the submucous plexus of the guinea‐pig oesophagus.
Br. J. Pharmacol.
78:
693–699,
1983.
|
| 331. |
Kangawa, K.,
N. Minamino,
A. Fukuda, and
H. Matsuo.
Neuromedin K: a novel mammalian tachykinin identified in porcine spinal cord.
Biochem. Biophys. Res. Commun.
114:
533–540,
1983.
|
| 332. |
Karaus, M., and
S. K. Sarna.
Differential effects of Gln4‐neurotensin on circular and longitudinal muscle of dog ileum in vitro (Abstract).
Dig. Dis. Sci.
30:
776,
1985.
|
| 333. |
Karras, P. J., and
R. A. North.
Acute and chronic effects of opiates on single neurons of the myenteric plexus.
J. Pharmacol. Exp. Ther.
217:
70–80,
1981.
|
| 334. |
Katayama, Y., and
R. A. North.
Does substance P mediate slow synaptic excitation within the myenteric plexus?
Nature Lond.
274:
387–388,
1978.
|
| 335. |
Katayama, Y., and
R. A. North.
The action of somatostatin on neurons of the myenteric plexus of the guinea pig ileum.
J. Physiol. Lond.
303:
315–323,
1980.
|
| 336. |
Katayama, Y.,
R. A. North, and
J. T. Williams.
The action of substance P on neurones of the myenteric plexus of the guinea‐pig intestine.
Proc. R. Soc. Lond. B Biol. Sci.
206:
191–208,
1979.
|
| 337. |
Kilbinger, H.,
S. Sharp,
I. Erlhof, and
P. Holzer.
Antagonist discrimination between subtypes of tachykinin receptors in the guinea‐pig ileum.
Naunyn‐Schmiedeberg's Arch. Pharmacol.
334:
181–197,
1986.
|
| 338. |
Kimura, S.,
M. Okada,
Y. Sugita,
I. Kanazawa, and
E. Munekata.
Novel neuropeptides, neurokinin α and β isolated from porcine spinal cord.
Proc. Jpn. Acad. Ser. B Phys. Biol. Sci.
59:
101–104,
1983.
|
| 339. |
Kitabgi, P.
Effects of neurotensin on intestinal smooth muscle: application of the study of structure activity relationships.
Ann. NY Acad. Sci.
400:
37–55,
1982.
|
| 340. |
Kitabgi, P.,
R. Carraway,
J. Van Rietschoten,
C. Granier,
J. L. Morgat,
A. Menez,
S. Leeman, and
P. Freychet.
Neurotensin: specific binding to synaptic membranes from rat brain.
Proc. Natl. Acad. Sci. USA
74:
1846–1850,
1977.
|
| 341. |
Kitabgi, P., and
P. Freychet.
Neurotensin: contractile activity, specific binding, and lack of effect on cyclic nucleotides in intestinal smooth muscle.
Eur. J. Pharmacol.
55:
35–42,
1979.
|
| 342. |
Kitabgi, P.,
C.‐Y. Kwan,
J. E. T. Fox, and
J. P. Vincent.
Characterization of neurotensin binding to rat gastric smooth muscle receptor sites.
Peptides Fayetteville
5:
917–923,
1984.
|
| 343. |
Kitabgi, P.,
C. Poustis,
C. Granier,
J. Van Rietschoten,
J. Rivier,
J. L. Morgat, and
P. Freychet.
Neurotensin binding to extraneural and neural receptors: comparison with biological activity and structure‐activity relationships
Mol. Pharmacol.
18:
11–19,
1980.
|
| 344. |
Konturek, S.J.
Endogenous opiates and the digestive system.
Scand. J. Gastroenterol.
13:
257–261,
1978.
|
| 345. |
Konturek, S. J.,
W. Pawlik,
K. Walus,
D. H. Coy, and
A. V. Schally.
Methionine‐enkephalin stimulates gastric secretion and gastric mucosal blood flow.
Proc. Soc. Exp. Biol. Med.
158:
156–160,
1978.
|
| 346. |
Konturek, S. J.,
P. J. Thor,
J. Bilski,
W. Bielanski, and
J. Laskiewicz.
Relationship between duodenal motility and pancreatic secretion in fasted and fed dogs.
Am. J. Physiol.
250
(Gastrointest. Liver Physiol. 13):
G570–G574,
1986.
|
| 347. |
Konturek, S. J.,
P. Thor,
R. Krol,
A. Dembinski, and
A. V. Schally.
Influence of methionine‐enkephalin and morphine activity on myoelectric of small bowel.
Am. J. Physiol.
238
(Gastrointest. Liver Physiol. 1):
G384–G389,
1980.
|
| 348. |
Korchak, D. M.,
M. Laskowski, and
M. C. Beinfeld.
Brain motilin‐like peptides are localized within the cell nucleus.
Peptides Fayetteville
6:
1119–1123,
1985.
|
| 349. |
Kostka, P.,
S. Ahmad,
I. Berezin,
H. D. Allescher,
C.‐Y. Kwan, and
E. E. Daniel.
Subcellular fractionation of the longitudinal smooth muscle/myenteric plexus (LSM/MP) of dog ileum. Dissociation of the distribution of two plasma membrane marker enzymes.
J. Neurochem.
44:
1124–1132,
1987.
|
| 350. |
Krejs, G. J.
Physiological role of somatostatin in the digestive tract: gastric acid secretion, intestinal absorption and motility. Scand.
J. Gastroenterol.
21:
47–53,
1986.
|
| 351. |
Kwan, C.‐Y.,
Y. Sakai,
A. K. Grover, and
R. M. K. Lee.
Isolation and characterization of plasma membrane fraction from gastric fundus smooth muscle of the rat.
Mol. Physiol.
2:
107–120,
1982.
|
| 352. |
Laburthe, M.,
A. Couvineau, and
C. H. Rowyer‐Fessard.
Study of species specificity in growth hormone‐releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac‐Tyr1hGRF is a competitive VIP antagonist in the rat.
Mol. Pharmacol.
29:
23–27,
1986.
|
| 353. |
Lazarus, L. H.,
R. I. Linnoila,
O. Hernandez, and
R. Diaugustine.
A neuropeptide in mammalian tissues with physalaemin‐like immunoreactivity.
Nature Lond.
287:
555–558,
1980.
|
| 354. |
Leander, S.,
E. Brodin,
R. Håkanson,
F. Sundler, and
R. Uddman.
Neuronal substance P in the esophagus. Distribution and effects of motor activity.
Acta Physiol. Scand.
115:
427–435,
1982.
|
| 355. |
Leander, S.,
R. Ekman,
R. Uddman,
F. Sundler, and
R. Håkanson.
Neuronal cholecystokinin, gastrin releasing peptide, neurotensin and α‐endorphin in the intestine of the guinea pig.
Cell Tissue Res.
235:
521–531,
1984.
|
| 356. |
Lee, K. Y.,
T. M. Chang, and
W. Y. Chey.
Effect of rabbit antimotilin serum on myoelectric activity and plasma motilin concentration in the fasting dog. Am.
J. Physiol.
245
(Gastrointest. Liver Physiol. 8):
G547–G553,
1983.
|
| 357. |
Lee, K. Y.,
W. Chey,
H. H. Tai, and
H. Yajima.
Radioimmunoassay of motilin.
Am. J. Dig. Dis.
23:
789–795,
1978.
|
| 358. |
Leeman, S. E.
Substance P and neurotensin: discovery, isolation, chemical characterization and physiological studies.
J. Exp. Biol.
89:
193–200,
1980.
|
| 359. |
Leeman, S. E., and
N. D. Boyd.
Substance P: discovery, isolation and structure: inhibitory effects on nicotinic cholinergic activation in a neuronal cell line. In:
Substance P Dublin 1983,
edited by
P. Skrabanek and
D. Powell.
Dublin:
Boole,
1983,
p. 1–5.
|
| 360. |
Leeman, S. E., and
R. E. Carraway.
Neurotensin: discovery, isolation, characterization, synthesis and possible physiological roles.
Ann. NY Acad. Sci.
400:
1–16,
1982.
|
| 361. |
Lemaire, S., and
A. Turcotte.
Synthesis and biological activity of analogs of dynorphin‐A(1–13) substituted in positions 2 and 4: design of [Ala2,Trp4]‐Dyn‐A(1–13) as a putative selective opioid antagonist.
Can. J. Physiol Pharmacol.
64:
673–678,
1986.
|
| 362. |
Lemoyne, M.,
R. Wassef,
D. Tasse,
L. Trudel, and
P. Poitras.
Motilin and the vagus in dogs.
Can. J. Physiol. Pharmacol.
62:
1092–1096,
1984.
|
| 363. |
Leslie, F. M.,
C. Chavkin, and
B. M. Cox.
Opioid binding properties of brain and peripheral tissues: evidence for heterogeneity in opioid ligand binding sites.
J. Pharmacol. Exp. Ther.
214:
395–402,
1980.
|
| 364. |
Lewin, M. J. M.
Somatostatin receptors.
Scand. J. Gastroenterol.
21:
42–46,
1986.
|
| 365. |
Lewis, T. D.,
S. M. Collins,
J. E. T. Fox, and
E. E. Daniel.
Initiation of duodenal acid‐induced motor complexes.
Gastroenterology
77:
1217–1224,
1979.
|
| 366. |
Lidberg, P.
On the role of substance P and serotonin in the pyloric motor control. An experimental study in cat and rat.
Acta Physiol. Scand. Suppl.
538:
1–69,
1985.
|
| 367. |
Lidberg, P.,
A. Dahlström, and
H. Ahlman.
On the nature of the contractile motor responses of the rat stomach elicited by serotonin or substance P.
J. Neural Transm.
63:
73–89,
1985.
|
| 368. |
Lidberg, P.,
A. Dahlström,
J. M. Lundberg, and
H. Ahlman.
Different modes of action of substance P in the motor control of the feline stomach and pylorus.
Regul. Pept.
7:
41–52,
1983.
|
| 369. |
Lidberg, P.,
R. Edin,
J. M. Lundberg,
A. Dahlström,
S. Rosell,
K. Folkers, and
H. Ahlman.
The involvement of substance P in the vagal control of the feline pylorus.
Acta Physiol. Scand.
114:
307–309,
1982.
|
| 370. |
Lipshutz, W. H., and
S. Cohen.
Physiologic determinants of lower esophageal sphincter function.
Gastroenterology
61:
16–24,
1971.
|
| 371. |
Lipshutz, W. H.,
A. F. Tuch, and
S. Cohen.
A comparison of the site of action of gastrin I on lower esophageal sphincter and antral circular smooth muscle.
Gastroenterology
61:
454–460,
1971.
|
| 372. |
Loesch, A., and
G. Burnstock.
Ultrastructural identification of VIP‐containing nerve fibers in the myenteric plexus of the rat ileum.
J. Neurocytol.
14:
327–335,
1985.
|
| 373. |
Lord, J. A. H.,
A. A. Waterfield,
J. Hughes, and
H. W. Kosterlitz.
Endogenous opioid peptides: multiple agonists and receptors.
Nature Land.
267:
495–499,
1977.
|
| 374. |
Lucey, M. R.
Endogenous somatostatin and the gut.
Gut
27:
457–467,
1986.
|
| 375. |
Lundberg, J. M., and
A. Saria.
Capsaicin‐induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants.
Nature Lond.
302:
251–253,
1983.
|
| 376. |
MacDonald, R. L., and
M. A. Werz.
Dynorphin A decreases voltage‐dependent calcium conductance of mouse doral root ganglion neurones.
J. Physiol. Lond.
377:
237–249,
1986.
|
| 377. |
MacKenzie, I., and
G. Burnstock.
Evidence against VIP being the non‐adrenergic, non‐cholinergic inhibitory transmitter released from nerves supplying the smooth muscle of the guinea pig taenia coli.
Eur. J. Pharmacol.
67:
255–264,
1980.
|
| 378. |
Magee, D. F., and
S. Naruse.
The role of motilin in periodic interdigestive pancreatic secretion in dogs.
J. Physiol. Lond.
355:
441–447,
1984.
|
| 379. |
Maggi, C. A.,
S. Guiliani,
S. Manzini,
P. Santicioli, and
A. Meli.
Motor effect of neurokinins on the rat duodenum: evidence for the involvement of substance K and substance P receptors.
J. Pharmacol. Exp. Ther.
238:
341–351,
1986.
|
| 380. |
Mailman, D.
Effects of morphine on canine intestinal absorption and blood flow.
Br. J. Pharmacol.
68:
617–624,
1980.
|
| 381. |
Makhlouf, G. M.,
S. Said, and
J. R. Grider.
Vasoactive intestinal peptide as a neural transmitter of gastric relaxation.
Am. J. Physiol.
248
(Gastrointest. Liver Physiol. 11):
G73–G78,
1985.
|
| 382. |
Manara, L.,
G. Bianchi,
P. Ferretti, and
A. Tavani.
Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.
J. Pharmacol. Exp. Ther.
237:
945–949,
1986.
|
| 383. |
Mantyh, P. W.,
J. E. Maggio, and
S. P. Hunt.
The autoradiographic distribution of kassinin and substance K binding sites is different from the distribution of substance P binding sites in rat brain.
Eur. J. Pharmacol.
102:
361–364,
1984.
|
| 384. |
Martin, W. R.
Pharmacology of opioids.
Pharmacol. Rev.
35:
283–323,
1984.
|
| 385. |
Marvaldi, J.,
J. Luis,
J. M. Muller,
A. El Battari,
J. Fantini,
J. M. Martin,
B. Abadie,
A. Tirard, and
J. Pichon.
Characterization of the vasoactive intestinal peptide (VIP) binding sites: a biochemical and an immunological approach.
Peptides Fayetteville
7,
Suppl. 1:
137–145,
1986.
|
| 386. |
Matsumoto, T.,
S. K. Sarna,
R. E. Condon,
V. E. Cowles, and
C. Frantzides.
Differential sensitivities of morphine and motilin to initiate migrating motor complex in isolated intestinal segments. Regeneration of intrinsic nerves.
Gastroenterology
90:
61–67,
1986.
|
| 387. |
Mayer, E. A.,
G. V. Deventer,
J. Elashoff,
S. Khawaja, and
J. Walsh.
Characterization of substance P effects on canine antral muscle.
Am. J. Physiol.
251
(Gastrointest. Liver Physiol. 14):
G140–G146,
1986.
|
| 388. |
Mayer, E. A.,
J. Elashoff, and
J. H. Walsh.
Characterizations of bombesin effects on canine gastric muscle.
Am. J. Physiol. (Gastrointest. Liver Physiol.
6):
243
G141–G147,
1982.
|
| 389. |
Mazella, J.,
C.‐Y. Kwan,
P. Kitabgi, and
J. P. Vincent.
Covalent labeling of neurotensin receptors in rat gastric fundus plasma membranes.
Peptides Fayetteville
6:
1137–1141,
1985.
|
| 390. |
Mazurek, N.,
I. Pecht,
V. I. Teichberg, and
S. Blumberg.
The role of the N‐terminal tetrapeptide in the histamine releasing action of substance P.
Neuropharmacology
20:
1025–1027,
1981.
|
| 391. |
McDonald, T. J., and
J. E. T. Fox.
Effects of porcine gastrin releasing peptide (GRP) in canine antral motility and gastrin release in vivo.
Life Sci.
35:
1415–1422,
1984.
|
| 392. |
McDonald, T. J.,
G. Nilsson,
M. Vagne,
M. A. Ghatei,
S. R. Bloom, and
V. Mutt.
A gastrin releasing peptide from the porcine nonantral gastric tissue.
Gut
19:
767–774,
1978.
|
| 393. |
McIntosh, C.
Gastrointestinal somatostatin: Distribution, secretion and physiological significance.
Life Sci.
37:
2043–2058,
1985.
|
| 394. |
McKirdy, H. C., and
R. W. Marshall.
Effect of drugs and electrical field stimulation on circular muscle strips from human lower oesophagus.
Q. J. Exp. Physiol.
70:
591–601,
1985.
|
| 395. |
McLean, J., and
J. E. T. Fox.
Mechanism of action of neurotensin on motility of canine corpus in vitro.
Can. J. Physiol. Pharmacol.
61:
29–34,
1983.
|
| 396. |
Meissner, A. J.,
K. L. Bowes,
R. Zwick, and
E. E. Daniel.
Effect of motilin on the lower esophageal sphincter.
Gut
17:
925–932,
1976.
|
| 397. |
Melander, T.,
T. Hökfelt,
A. Rokaeus,
J. Fahrenkrug,
K. Tatemoto, and
V. Mutt.
Distribution of galanin‐like immunoreactivity in the gastrointestinal tract of several species.
Cell Tissue Res.
239:
253–270,
1985.
|
| 398. |
Melchiorri, P.
Bombesin‐like peptides activity in the gastrointestinal tract of mammals and birds. In:
Gastrointestinal Hormones,
edited by
G. B. Jersy Glass,
New York:
Raven
1980,
p. 717–725.
|
| 399. |
Mihara, S., and
R. A. North.
Opioids increase potassium conductance in submucous neurones of guinea‐pig caecum by activating δ‐receptors.
Br. J. Pharmacol.
88:
315–322,
1986.
|
| 400. |
Milenov, K., and
K. Golenhofen.
Differentiated contractile responses of gastric smooth muscle to substance P.
Pfluegers Arch.
397:
29–34,
1983.
|
| 401. |
Milenov, K.,
P. Oehme,
M. Bienert, and
J. Bergmann.
Effect of substance P on mechanical and myoelectrical activities of stomach and small intestines in conscious dog.
Arch. Int. Pharmacodyn. Ther.
233:
251–260,
1978.
|
| 402. |
Miller, C. A.,
M. S. Barnette,
H. S. Ormsbee III, and
T. J. Torphy.
Cyclic nucleotide‐dependent protein kinases in the lower esophageal sphincter.
Am. J. Physiol.
251
(Gastrointest. Liver Physiol. 14):
G794–G803,
1986.
|
| 403. |
Miller, L.,
J. S. Shaw, and
E. M. Whiting.
The contribution of intrinsic activity to the action of opioids in vitro.
Br. J. Pharmacol.
87:
595–601,
1986.
|
| 404. |
Minamino, N.,
K. Kangawa,
A. Fukuda, and
H. Matsuo.
Neuromedin L: a novel mammalian tachykinin identified in porcine spinal cord.
Neuropeptides
4:
157–166,
1984.
|
| 405. |
Minamino, N.,
K. Kangawa, and
H. Matsuo.
Neuromedin B: another bombesin‐like peptide identified in porcine spinal cord.
Biochem. Biophys. Res. Commun.
114:
541–548,
1983.
|
| 406. |
Minamino, N.,
K. Kangawa, and
H. Matsuo.
Neuromedin C: bombesin‐like peptide identified in porcine spinal cord.
Biochem. Biophys. Res. Commun.
119:
14–20,
1984.
|
| 407. |
Minamino, N.,
K. Kangawa, and
H. Matsuo.
Neuromedin N: a novel neurotensin‐like peptide identified in porcine spinal cord.
Biochem. Biophys. Res. Commun.
122:
542–549,
1984.
|
| 408. |
Mittal, R. K.,
E. B. Frank,
R. C. Lange, and
R. W. McCallum.
Effects of morphine and naloxone on esophageal motility and gastric emptying in man.
Dig. Dis. Sci.
31:
936–942,
1986.
|
| 409. |
Mitznegg, P.,
W. Domschke,
E. Wunsch,
S. R. Bloom,
S. Domschke, and
L. Demling.
Release of motilin after duodenal acidification.
Lancet
1:
888–889,
1976.
|
| 410. |
Mizrahi, J.,
S. Dion,
P. D'Orleans‐Juste, and
D. Regoli.
Activities and antagonism of bombesin on urinary smooth muscles.
Eur. J. Pharmacol.
111:
339–345,
1985.
|
| 411. |
Mizrahi, J.,
E. Escher,
S. Caranikas,
P. D'Orleans‐Juste, and
D. Regoli.
Substance P antagonists active in vitro and in vivo.
Eur. J. Pharmacol.
82:
101–105,
1982.
|
| 412. |
Modlin, I. M.,
P. Mitznegg, and
S. R. Bloom.
Motilin release in pig.
Gut
19:
399–402,
1978.
|
| 413. |
Mogard, M. H.,
J. R. Reeve,
J. E. Schivley,
C. M. Benavram,
V. E. Eysselein, and
J. H. Walsh.
Isolation and characterization of a neurotensin‐like decapeptide from a canine upper small intestinal extract.
Regul. Pept.
14:
313–321,
1986.
|
| 414. |
Monier, S., and
P. Kitabgi.
Substance P‐induced autodesensitization inhibits atropine‐resistant, neurotensin‐stimulated contraction in guinea‐pig ileum.
Eur. J. Pharmacol.
65:
461–462,
1980.
|
| 415. |
Morgan, K. G.,
F. Angel,
P. F. Schmalz, and
J. H. Szurszewski.
Intracellular electrical activity of muscularis mucosa of the dog stomach.
Am. J. Physiol.
249
(Gastrointest. Liver Physiol. 12):
G256–G263,
1985.
|
| 416. |
Morgan, K. G.,
P. F. Schmalz,
V. L. W. Go, and
J. H. Szurszewski.
Electrical and mechanical effects of molecular variants of CCK on antral smooth muscle.
Am. J. Physiol.
235
(Endocrinol. Metab. Gastrointest. Physiol. 4):
E324–E329,
1978.
|
| 417. |
Morgan, K. G.,
P. F. Schmalz,
V. L. W. Go, and
J. H. Szurszewski.
Effects of pentagastrin, G17 and G34, on the electrical and mechanical activities of canine antral smooth muscle.
Gastroenterology
74:
405–412,
1978.
|
| 418. |
Morgan, K. G.,
P. Schmalz, and
J. H. Szurszewski.
The inhibitory effects of vasoactive intestinal polypeptide on the mechanical and electrical activity of canine antral smooth muscle.
J. Physiol. Lond.
282:
437–450,
1978.
|
| 419. |
Morgan, K. G., and
J. H. Szurszewski.
Mechanisms of phasic and tonic action of pentagastrin on canine gastric smooth muscle.
J. Physiol. Lond.
301:
229–242,
1980.
|
| 420. |
Morita, K., and
R. A. North.
Opiates and enkephalin reduce the excitability of neuronal processes.
Neuroscience
6:
1943–1951,
1981.
|
| 421. |
Morita, K., and
R. A. North.
Opiate activation of potassium conductance in guinea pig myenteric neurones: inhibition by calcium ions.
Brain Res.
242:
145–150,
1982.
|
| 422. |
Morley, J. E.,
A. S. Levine,
T. Yamada,
R. L. Gebhard,
W. F. Prigge,
R. B. Shafer,
F. C. Goetz, and
S. E. Silvis.
Effect of exorphins on gastrointestinal function, hormonal release, and appetite.
Gastroenterology
84:
1517–1523,
1983.
|
| 423. |
Muallem, S., and
G. Sachs.
Ca2+ regulation by endoplasmic reticulum. In:
Regulatory Peptides in Digestive, Nervous and Endocrine Systems,
edited by
M. J. M. Lewin and
S. Bonfils.
Amsterdam:
Elsevier,
1985,
p. 69–76.
|
| 424. |
Mukhopadhyay, A. K.
Effect of substance P on the lower esophageal sphincter of the opossum.
Gastroenterology
75:
278–282,
1978.
|
| 425. |
Mukhopadhyay, A. K., and
M. Kunnemann.
Mechanism of lower esophageal sphincter stimulation by bombesin in the opossum.
Gastroenterology
76:
1409–1414,
1979.
|
| 426. |
Müller, J. M.,
A. El Battari,
E. Ah‐Kye,
J. Luis,
F. Ducret,
J. Pichon, and
J. Marvaldi.
Internalization of the vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT 29).
Eur. J. Biochem.
152:
107–114,
1985.
|
| 427. |
Nau, R.,
G. Schäfer,
C. F. Deacon,
T. Cole,
D. V. Agoston, and
J. M. Conlon.
Proteolytic inactivation of substance P and neurokinin A in the longitudinal muscle layer of guinea‐pig small intestine.
J. Neurochem.
47:
856–864,
1986.
|
| 428. |
Nawa, H.,
T. Hirose,
H. Takashima,
S. Inayama, and
S. Nakamishi.
Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor.
Nature Lond.
206:
32–36,
1983.
|
| 429. |
Nawa, H.,
H. Kotani, and
S. Nakanishi.
Tissue‐specific generation of two preprotachykinin RNAs from one gene by alternative RNA splicing.
Nature Lond.
312:
729–734,
1984.
|
| 430. |
Nemeth, P. R.,
W. R. Ewart, and
J. D. Wood.
Effects of the putative substance P antagonists [d‐Pro2,d‐Phe7,d‐Trp9] and [d‐Pro2,d‐Trp7,9] on electrical activity and myenteric neurons.
J. Auton. Nerv. Syst.
8:
165–169,
1983.
|
| 431. |
Neya, T.,
T. Yamasato,
M. Takaki,
M. Mizutani, and
S. Nakayama.
Excitatory and inhibitory effects of vasoactive intestinal polypeptide (VIP) on the isolated jejunum and internal anal sphincter in the guinea pig.
Biomed. Res.
2:
398–403,
1981.
|
| 432. |
Niel, M. P.,
R. A. R. Bywater, and
G. S. Taylor.
Apamin‐resistant post‐stimulus hyperpolarization in the circular muscle of the guinea‐pig ileum.
J. Auton. Nerv. Syst.
9:
565–569,
1983.
|
| 433. |
Niel, J. P.,
R. A. R. Bywater, and
G. S. Taylor.
Effect of substance P on non‐cholinergic fast and slow past‐stimulus depolarization in the guinea‐pig ileum.
J. Auton. Nerv. Syst.
9:
573–584,
1983.
|
| 434. |
Nilaver, G.,
R. Defendini,
E. A. Zimmerman,
M. C. Beinfeld, and
T. L. O'Donohue.
Motilin in the purkinje cell of the cerebellum.
Nature Lond.
295:
597–598,
1982.
|
| 435. |
Nilsson, A.
Structure of the vasoactive intestinal octacosa‐peptide from chicken intestine. The amino acid sequence.
FEBS Lett.
60:
321–327,
1975.
|
| 436. |
Nilsson, S.,
S. Leander,
S. Vallgren, and
R. Hakanson.
Gastrins and cholecystokinins release acetylcholine but not substance P from neurones in the guinea pig taenia coli.
Eur. J. Pharmacol.
90:
245–250,
1983.
|
| 437. |
North, R. A.
Opioid receptor types and membrane ion channels.
Trends Neurosci.
7:
114–117,
1986.
|
| 438. |
North, R. A.,
Y. Katayama, and
J. T. Williams.
On the mechanism and site of action of enkephalin on single myenteric neurons.
Brain Res.
165:
67–77,
1979.
|
| 439. |
O'Donohue, T. L.,
M. C. Beinfeld,
W. Y. Chey,
T. M. Chang,
G. Nilaver,
E. A. Zimmerman,
H. Yajima,
H. Adachi,
M. Poth,
R. P. McDevitt, and
D. M. Jakobowitz.
Identification, characterization and distribution of motilin immunoreactivity in the rat central nervous system.
Peptides Fayetteville
2:
467–477,
1981.
|
| 440. |
Ohkawa, H.
Effects of neurotensin on the non‐adrenergic inhibitory neurotransmission in the guinea‐pig duodenum.
Jpn. J. Physiol.
35:
973–983,
1985.
|
| 441. |
Ohkawa, H., and
M. Watanabe.
Effects of gastrointestinal hormones on the electrical and mechanical activities of the cat small intestine.
Jpn. J. Physiol.
27:
71–79,
1977.
|
| 442. |
Oka, K.,
J. D. Kantrowitz, and
S. Spector.
Isolation of morphine from toad skin.
Proc. Natl. Acad. Sci. USA
82:
1852–1854,
1985.
|
| 443. |
Oka, T.
Enkephalin (opiate) receptors in the intestine.
Trends Pharmacol. Sci.
2:
328–330,
1981.
|
| 444. |
O'Morain, C.,
A. E. Bishop,
G. P. McGregor,
A. J. Levi,
S. R. Bloom,
J. M. Polak, and
T. J. Peters.
Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease.
Gut
25:
57–61,
1984.
|
| 445. |
Ondetti, M. A.,
B. Rubin,
S. Engel,
J. Plusec, and
J. T. Sheehan.
Cholecystokinin‐pancreozymin: recent developments.
Am. J. Dig. Dis.
15:
149–156,
1970.
|
| 446. |
Orloff, M. S.,
A. J. Turner, and
N. W. Bunnett.
Catabolism of substance P and neurotensin in the rat stomach wall is susceptible to inhibitors of angiotensin converting enzyme.
Regul. Pept.
14:
21–31,
1986.
|
| 447. |
Ormsbee, H. S., III,
G. L. Telford, and
G. R. Mason.
Required neural involvement in control of canine migrating motor complex.
Am. J. Physiol.
237
(Endocrinol. Metab. Gastrointest. Physiol. 6):
E451–E456,
1979.
|
| 448. |
Ouyang, A.,
C. J. Clain,
W. J. Snape, Jr., and
S. Cohen.
Characterization of opiate‐mediated responses of the feline ileum and ileocecal sphincter.
J. Clin. Invest.
69:
507–515,
1982.
|
| 449. |
Palmer, J. M.,
M. Schemann,
K. Tamura, and
J. D. Wood.
Galanin mimics slow synaptic inhibition in myentric neurons.
Eur. J. Pharmacol.
124:
379–380,
1986.
|
| 450. |
Pandol, J.,
K. Dharmsathaphorn,
M. S. Schoeffield,
W. Vale, and
J. Rivier.
Vasoactive intestinal peptide receptor antagonist [4 CI‐d‐Phe6,Leu17] VIP.
Am. J. Physiol.
250
(Gastrointest. Liver Physiol. 13):
G553–G557,
1986.
|
| 451. |
Patel, Y. C., and
G. S. Tannenbaum.
Somatostatin.
New York:
Plenum,
1985.
|
| 452. |
Paton, W. D. M.
The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea‐pig ileum.
Br. J. Pharmacol.
35:
119–127,
1957.
|
| 453. |
Pearse, A. G. E.
The cellular origin of motilin in the gastrointestinal tract.
Scand. J. Gastroenterol.
11:
35–38,
1976.
|
| 454. |
Peeters, T. L.,
V. Bormans,
G. Matthijs, and
G. Vantrappen.
Comparison of the biological activity of canine and porcine motilin in rabbit.
Regul. Pept.
15:
333–339,
1986.
|
| 455. |
Peeters, T. L.,
J. Janssens, and
G. Vantrappen.
Somatostatin and the interdigestive migrating motor complex in man.
Regul. Pept.
5:
209–217,
1983.
|
| 456. |
Pinnington, J., and
D. L. Wingate.
The effects of motilin on periodic myoelectric spike activity in intact and transected canine small intestine.
J. Physiol. Lond.
337:
471–478,
1983.
|
| 457. |
Plant, O. H., and
G. H. Miller.
Effects of morphine and some other opium alkaloids on the muscular activity of the alimentary canal. 1. Action on the small intestine of the unanesthetized dog and man.
J. Pharmacol. Exp. Ther.
27:
361–383,
1927.
|
| 458. |
Poitras, P.,
C. Honde,
J. Havrankova,
R. G. Lahaie,
L. Trudel,
R. Goyer,
J. L. Junien, and
X. Pascaud.
Effect of trimebutine on intestinal motility and plasma motilin in the dog.
Am. J. Physiol.
251
(Gastrointest. Liver Physiol. 14):
G349–G353,
1986.
|
| 459. |
Poitras, P.,
J. R. Reeve, Jr.,
M. W. Hunkapiller,
L. E. Hood, and
J. H. Walsh.
Purification and characterization of canine intestinal motilin.
Regul. Pept.
5:
197–208,
1983.
|
| 460. |
Poitras, P.,
J. H. Steinbach,
G. Vandeventer,
C. F. Code, and
J. H. Walsh.
Motilin‐independent ectopic fronts of the interdigestive myoelectric complex in dogs.
Am. J. Physiol.
239
(Gastrointest. Liver Physiol. 2):
G215–G220,
1980.
|
| 461. |
Polak, J. M., and
S. R. Bloom.
The central and peripheral distribution of neurotensin.
Ann. NY Acad. Sci.
400:
75–93,
1982.
|
| 462. |
Pomeranz, I. S.,
J. S. Davison, and
E. A. Shaffer.
In vitro effects of pancreatic polypeptide and motilin on contractility of human gallbladder.
Dig. Dis. Sci.
28:
539–544,
1983.
|
| 463. |
Porreca, F., and
T. F. Burks.
The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
J. Pharmacol. Exp. Ther.
227:
22–27,
1983.
|
| 464. |
Porreca, F., and
A. Dray.
Motilin acts within the CNS to inhibit urinary bladder contractions.
Life Sci.
34:
2577–2581,
1984.
|
| 465. |
Porreca, F.,
J. J. Galligan, and
T. F. Burks.
Central opioid receptor involvement in gastrointestinal motility.
Trends Pharmacol. Sci.
7:
104–107,
1986.
|
| 466. |
Porreca, F.,
H. I. Mosberg,
R. Hurst,
V. J. Hruby, and
T. F. Burks.
Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot‐plate analgesia in the mouse.
J. Pharmacol. Exp. Ther.
230:
341–348,
1984.
|
| 467. |
Portoghese, P. S.,
D. L. Larson,
J. B. Jiang,
T. P. Caruso, and
A. E. Takemori.
Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong‐lasting narcotic antagonist properties.
J. Med. Chem.
22:
168–173,
1979.
|
| 468. |
Portoghese, P. S.,
D. L. Larson,
L. M. Sayre,
D. S. Fries, and
A. E. Takemori.
A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonist and reversible agonist activities.
J. Med. Chem.
23:
233–234,
1980.
|
| 469. |
Prieto, J. C.,
M. Laburthe, and
G. Rosselin.
Interaction of vasoactive intestinal peptide with isolated intestinal cells from rat. 1. Characterization, quantitative aspects and structural requirements of binding sites.
Eur. J. Biochem.
96:
229–237,
1979.
|
| 470. |
Probert, L.,
J. Demey, and
J. M. Polak.
Ultrastructural localization of four different neuropeptides within separate populations of p‐type nerves in the guinea pig colon.
Gastroenterology
85:
1094–1104,
1983.
|
| 471. |
Puttfarcken, P.,
L. L. Werling,
S. R. Brown,
T. E. Cote, and
B. M. Cox.
Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at ä‐and δ‐type receptors in 7315c and Ng108‐15 cells and cell membranes.
Mol. Pharmacol.
30:
81–89,
1986.
|
| 472. |
Quirion, R.
Multiple tachykinin receptors.
Trends Neurosci.
8:
183–185,
1985.
|
| 473. |
Quirion, R.,
D. Regoli,
F. Rioux, and
S. St. Pierre.
The stimulatory effect of neurotensin and related peptides in rat stomach strips and guinea pig atria.
Br. J. Pharmacol.
68:
83–91,
1980.
|
| 474. |
Quirion, R.,
D. Regoli,
F. Rioux, and
S. St. Pierre.
Structure activity studies with neurotensin: analysis of positions 9, 10 and 11.
Br. J. Pharmacol.
69:
689–692,
1980.
|
| 475. |
Rattan, S.,
D. Coln, and
R. K. Goyal.
The mechanism of action of gastrin on the lower esophageal sphincter.
Gastroenterology
70:
828–831,
1976.
|
| 476. |
Rattan, S., and
R. K. Goyal.
Neural control of the lower esophageal sphincter of the opossum. Influence of the vagus nerve.
J. Clin. Invest.
54:
899–906,
1974.
|
| 477. |
Rattan, S., and
R. K. Goyal.
Identification and localization of opioid receptors in the opossum lower esophageal sphincter.
J. Pharmacol. Exp. Ther.
224:
391–397,
1983.
|
| 478. |
Rattan, S.,
M. Grady, and
R. K. Goyal.
Vasoactive intestinal peptide causes peristaltic contractions in the esophageal body.
Life Sci.
30:
1557–1563,
1982.
|
| 479. |
Rattan, S.,
S. I. Said, and
R. K. Goyal.
Effect of vasoactive intestinal polypeptide on lower esophageal sphincter pressure.
Proc. Soc. Exp. Biol. Med.
155:
40–43,
1977.
|
| 480. |
Rattan, S.,
J. H. Walsh, and
R. K. Goyal.
Distribution of vasoactive intestinal polypeptide (VIP) in the opossum esophagus (Abstract).
Dig. Dis. Sci.
25:
729,
1980.
|
| 481. |
Regoli, D.,
S. Dion,
G. Drapeau,
N. E. Rahleb, and
P. D'Orleans‐Juste.
Specific and sensitive new bioassays for neurokinins (substance P and congeners). In:
Smooth Muscle Function Symp. Proc,
edited by
E. E. Daniel.
Hamilton, Canada:
McMaster,
1986,
p. 118.
|
| 482. |
Regoli, D.,
J. Mizrahi,
P. D'Orleans‐Juste,
S. Dion,
G. Drapeau, and
E. Escher.
Substance P antagonists showing some selectivity for different receptor types.
Eur. J. Pharmacol.
109:
121–125,
1985.
|
| 483. |
Rehfeld, J. F.
Four basic characteristics of the gastrin‐cholecystokinin system.
Am. J. Physiol.
240
(Gastrointest. Liver Physiol. 3):
G255–G266,
1981.
|
| 484. |
Reichlin, S.
Somatostatin I.
N. Engl. J. Med.
309:
1495–1501,
1983.
|
| 485. |
Reichlin, S.
Somatostatin II.
N. Engl. J. Med.
309:
1556–1563,
1983.
|
| 486. |
Reichlin, S.
Somatostatin: historical aspects.
Scand. J. Gastroenterol.
21:
1–10,
1986.
|
| 487. |
Reinecke, M.,
R. E. Carraway,
S. Falkmer,
G. E. Feirde, and
W. G. Forssman.
Occurrence of neurotensin‐immunoreactive cells in the digestive tract of lower vertebrates and deuterostomian invertebrates.
Cell Tissue Res.
212:
173–183,
1980.
|
| 488. |
Remington, M.,
J. R. Malagelada,
A. Zinsmeister, and
C. R. Fleming.
Abnormalities in gastrointestinal motor activity in patients with short bowels: effect of a synthetic opiate.
Gastroenterology
85:
629–636,
1983.
|
| 489. |
Renny, A.,
W. J. Snape, Jr.,
E. A. Sun,
R. London, and
S. Cohen.
Role of cholecystokinin in the gastrocolic response to a fat meal.
Gastroenterology
85:
117–21,
1983.
|
| 490. |
Reynolds, J. C.,
M. R. Dukehart,
A. Ouyang, and
S. Cohen.
Interactions of bombesin and substance P at the feline lower esophageal sphincter.
J. Clin. Invest.
77:
436–440,
1986.
|
| 491. |
Reynolds, J. C.,
A. Ouyang, and
S. Cohen.
Evidence for an opiate‐mediated pyloric sphincter reflex.
Am. J. Physiol.
246
(Gastrointest. Liver Physiol. 9):
G130–G136,
1984.
|
| 492. |
Reynolds, J. C.,
A. Ouyang, and
S. Cohen.
A lower esophageal sphincter reflex involving substance P.
Am. J. Physiol.
246
(Gastrointest. Liver Physiol. 9):
G346–G354,
1984.
|
| 493. |
Reynolds, J. C.,
A. Ouyang, and
S. Cohen.
Opiate nerves mediate feline pyloric response to intraduodenal amino acids.
Am. J. Physiol.
248
(Gastrointest. Liver Physiol. 11):
G307–G312,
1985.
|
| 494. |
Robberecht, P.,
M. Waelbroek,
J. P. Dehaye,
J. Winand,
A. Vandermeers,
M. C. Vandermeers‐Piret, and
J. Christophe.
Evidence that helodermin, a newly extracted peptide from Gila monster venom, is a member of the secretin/VIP/PHI family of peptides with an original pattern of biological properties.
FEBS Lett.
166:
277–282,
1984.
|
| 495. |
Robotham, H.,
J. Jury, and
E. E. Daniel.
Capsaicin effects on muscularis mucosa of opossum esophagus: substance P release from afferent nerves?
Am. J. Physiol.
248
(Gastrointest. Liver Physiol. 11):
G655–G662,
1985.
|
| 496. |
Rokaeus, A.
Galanin—a newly isolated biologically active neuropeptide.
Trends Neurosci.
10:
158–164,
1987.
|
| 497. |
Rokaeus, A.,
T. Melander,
T. Hökfelt,
J. M. Rundberg,
K. Tatemoto,
M. Carlquist, and
V. Mutt.
A galanin‐like peptide in the central nervous system of the rat.
Neurosci. Lett.
47:
161–166,
1984.
|
| 498. |
Rosell, S.,
U. Björkroth,
J. C. Xu, and
K. Folkers.
The pharmacological profile of a substance P (SP) antagonist. Evidence for the existence of subpopulations of SP receptors. Acta.
Physiol. Scand.
117:
445–449,
1983.
|
| 499. |
Rosselin, G.
The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity.
Peptides Fayetteville
7,
Suppl. 1:
89–100,
1986.
|
| 500. |
Roszkowski, A. P.
An unusual type of sympathetic ganglion stimulant.
J. Pharmacol. Exp. Ther.
132:
156–170,
1961.
|
| 501. |
Ruckebusch, Y.,
T. Bardon, and
M. Pairet.
Opioid control of the ruminant stomach motility: functional importance of ä, κ and δ‐receptors.
Life Sci.
35:
1731–1738,
1984.
|
| 502. |
Ruckebusch, Y.,
J. P. Ferré, and
C. Du.
In vivo modulation of intestinal motility and sites of opioid effects in the rat.
Regul. Pept.
9:
109–117,
1984.
|
| 503. |
Ryan, J. P.
Motility of the gallbladder and biliary tree. In:
Physiology of the Gastrointestinal Tract,
edited by
L. R. Johnson.
New York:
Raven,
1981,
p. 473–494.
|
| 504. |
Ryan, J. P., and
S. Cohen.
Effect of vasoactive intestinal polypeptide on basal and cholecystokinin‐induced gallbladder pressure.
Gastroenterology
73:
870–871,
1977.
|
| 505. |
Ryan, J. P., and
S. Ryave.
Effect of vasoactive intestinal polypeptide on gallbladder smooth muscle in vitro.
Am. J. Physiol.
234
(Endocrinol. Metab. Gastrointest. Physiol. 3):
E44–E46,
1978.
|
| 506. |
Sadoul, J. L.,
J. Mazella,
S. Amar,
P. Kitabgi, and
J. P. Vincent.
Preparation of neurotensin selectively iodinated on the tyrosine‐3 residue. Biological activity and binding properties on mammalian neurotensin receptors.
Biochem. Biophys. Res. Commun.
120:
812–819,
1984.
|
| 507. |
Said, S. I., and
V. Mutt.
Isolation from porcine‐intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon.
Eur. J. Biochem.
28:
199–204,
1972.
|
| 508. |
Saito, A.,
H. Sankaran,
I. D. Goldfine, and
J. A. Williams.
Cholecystokinin receptors in the brain: characterization and distribution.
Science Wash. DC
208:
1155–1156,
1980.
|
| 509. |
Sakai, Y.,
E. E. Daniel,
J. Jury, and
J. E. T. Fox.
Neurotensin inhibition of canine intestinal motility in vivo via α2‐adrenoreceptors.
Can. J. Physiol. Pharmacol.
62:
403–411,
1984.
|
| 510. |
Sarna, S. K., and
R. S. Condon.
Morphine‐initiated migrating myoelectric complexes in the fed state in dogs.
Gastroenterology
86:
662–669,
1984.
|
| 511. |
Sarna, S. K.,
R. S. Condon, and
V. Cowles.
Enteric mechanisms of initiation of migrating myoelectric complexes in dogs.
Gastroenterology
84:
814–822,
1983.
|
| 512. |
Sarna, S. K.,
R. S. Condon, and
V. Cowles.
Morphine versus motilin in the initiation of migrating myoelectric complexes.
Am. J. Physiol.
245
(Gastrointest. Liver Physiol. 8):
G217–G220,
1983.
|
| 513. |
Schemann, M., and
H. J. Ehrlein.
Effects of neurohormonal agents on jejunal contraction spread and transit in the fed dog.
Gastroenterology
90:
1950–1955,
1986.
|
| 514. |
Scheufler, E., and
G. Zetler.
Interactions of caerulein and morphine on gastrointestinal propulsion in the mouse.
Naunyn‐Schmiedeberg's Arch. Pharmacol.
318:
66–69,
1981.
|
| 515. |
Scheurer, U.,
E. Drack, and
F. Halter.
Cyclooxygenase inhibitors affect met‐enkephalin‐ and acetycholine‐stimulated motility of the isolated rat colon.
J. Pharmacol. Exp. Ther.
234:
742–746,
1985.
|
| 516. |
Scheurer, U.,
E. Drack,
L. Varga, and
F. Halter.
Morphinelike action of enkephalin analog FK 33–824 on motility of the isolated rat colon.
J. Pharmacol. Exp. Ther.
219:
534–539,
1981.
|
| 517. |
Scheurer, U.,
L. Varga,
E. Drack,
H.‐R. Burki, and
F. Halter.
Mechanism of action of CCK‐OP on rat antrum, pylorus and duodenum.
Am. J. Physiol.
244
(Gastrointest. Liver Physiol. 7):
G266–G272,
1983.
|
| 518. |
Schick, R., and
V. Schusdziarra.
Modulation of motilin‐induced somatostatin release in dogs by naloxone.
Peptides Fayetteville
6:
861–864,
1985.
|
| 519. |
Schiller, L. R.,
G. R. Davis,
C. A. Santa Ana,
S. G. Morawski, and
J. S. Fordtran.
Studies on the mechanism of the antidiarrheal effect of codeine.
J. Clin. Invest.
70:
999–1008,
1982.
|
| 520. |
Schippers, E.,
J. Janssens,
G. Vantrappen,
M. Vandeweerd, and
T. L. Peeters.
Somatostatin induces ectopic activity fronts via a local intestinal mechanism during fed state or pentagastrin.
Am. J. Physiol.
250
(Gastrointest. Liver Physiol. 13):
G149–G154,
1986.
|
| 521. |
Schotte, A.,
J. E. Leysen, and
P. M. Laduron.
Evidence for a displaceable non‐specific [3H]neurotensin binding site in rat brain.
Naunyn‐Schmiedeberg's Arch. Pharmacol.
333:
400–405,
1986.
|
| 522. |
Schultz, R.,
K. Metzner,
T. Dandekar, and
C. Gramsch.
Opiates induce long‐term increases in prodynorphin‐derived peptide levels in the guinea‐pig myenteric plexus.
Naunyn‐Schmiedeberg's Arch. Pharmacol.
333:
381–386,
1986.
|
| 523. |
Schultz, R.,
E. Seidl, and
A. Herz.
Opioid dependence in the guinea‐pig myenteric plexus is controlled by non‐tolerant and tolerant opioid receptors.
Eur. J. Pharmacol.
110:
335–341,
1985.
|
| 524. |
Schultz, R.,
E. Seidl,
M. Wuster, and
A. Herz.
Opioid dependence and cross‐dependence in the isolated guinea‐pig ileum.
Eur. J. Pharmacol.
84:
33–40,
1982.
|
| 525. |
Schultz, R.,
M. Wuster,
P. Rubini, and
A. Herz.
Functional opiate receptors in the guinea‐pig ileum: their differentiation by means of selective tolerance development.
J. Pharmacol. Exp. Ther.
219:
547–550,
1981.
|
| 526. |
Schultzberg, M.,
T. Hökfelt,
G. Nilsson,
L. Terenius,
J. F. Rehlfeld,
M. Brown,
R. Elde,
M. Goldstein, and
S. Said.
Distribution of peptide and catecholamine‐containing neurones in the gastrointestinal tract of rat and guinea pig: immunohistochemical studies with antisera to substance P, vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin‐cholecystokinin, neurotensin and dopamine β‐hydroxylase.
Neuroscience
5:
689–744,
1980.
|
| 527. |
Schusdziarra, V., and
R. Schmid.
Physiological and pathophysiological aspects of somatostatin.
Scand. J. Gastroenterol.
21:
29–41,
1986.
|
| 528. |
Schuurkes, J. A. J., and
G. A. Charbon.
Motility and hemodynamics of the canine gastrointestinal tract. Stimulation by pentagastrin, cholecystokinin and vasopressin.
Arch. Int. Pharmacodyn Ther.
236:
214–227,
1978.
|
| 529. |
Segawa, T.,
M. Nakano,
Y. Kai,
H. Kawatani, and
J. Yajima.
Effect of synthetic motilin and related polypeptides on contraction of gastrointestinal smooth muscle.
J. Pharm. Pharmacol.
28:
650–651,
1976.
|
| 530. |
Shanahan, F.,
J. A. Denburg,
J. E. T. Fox,
J. Bienenstock, and
A. D. Befus.
Mast cell heterogeneity. Effects of neuroenteric peptides on histamine release.
J. Immunol.
135:
1331–1337,
1985.
|
| 531. |
Shaw, C.,
L. Thim, and
J. M. Conlon.
[Ser1]neurotensin: isolation from guinea pig intestine.
FEBS Lett.
202:
187–192,
1986.
|
| 532. |
Shea‐Donohue, P. T.,
N. Adams,
J. Arnold, and
A. Dubois.
Effects of Met‐enkephalin and naloxone on gastric emptying and secretion in rhesus monkeys.
Am. J. Physiol.
245
(Gastrointest. Liver Physiol. 8):
G196–G200,
1983.
|
| 533. |
Shimo, Y., and
T. Ishii.
Potentiation by naloxone of nonadrenergic inhibitory response of guinea‐pig taenia coli.
Dokkyo J. Med. Sci.
6:
19–23,
1979.
|
| 534. |
Shin, S.,
K. Imagawa,
F., Shimizu,
E. Hashimura,
K. Nagai,
C. Yanaihara, and
N. Yanaihara.
Heterogeneity of immunoreactive motilin.
Endocrinol. Jpn.
1:
141–149,
1980.
|
| 535. |
Shook, J. E., and
W. L. Dewey.
Morphine dependence and diabetes. I. The development of morphine dependence in streptozotocin‐diabetic rats and spontaneously diabetic C57BL/KsJ mice.
J. Pharmacol. Exp. Ther.
237:
841–847,
1986.
|
| 536. |
Shook, J. E.,
J. F. Kachur,
D. A. Brase, and
W. A. Dewey.
Morphine dependence and diabetes. II. Alterations of normorphine potency in the guinea‐pig ileum and mouse vas deferens and of ileal morphine dependence by changes in glucose concentration.
J. Pharmacol. Exp. Ther.
237:
848–852,
1986.
|
| 537. |
Sims, S. M.,
J. V. Walsh, Jr., and
J. J. Singer.
Substance P and acetylcholine both suppress the same K+ current in dissociated smooth muscle cells. Am.
J. Physiol.
251
(Gastrointest. Liver Physiol. 14):
G580–G587,
1986.
|
| 538. |
Smith, G. T.,
T. H. Moran,
J. T. Coyle,
M. J. Kuhar,
T. L. O'Donahue, and
P. R. McHugh.
Anatomic localization of cholecystokinin receptors to the pyloric sphincter.
Am. J. Physiol.
246
(Regulatory Integrative Comp. Physiol. 15):
R127–R130,
1984.
|
| 539. |
Snape, W. J., Jr.
Effect of calcium on the neurohormonal stimulation of feline colonic smooth muscle.
Am. J. Physiol.
243
(Gastrointest. Liver Physiol. 6):
G134–G140,
1982.
|
| 540. |
Snape, W. J., Jr.,
C. M. Carlson, and
S. Cohen.
Colonic myoelectric activity in the irritable bowel syndrome.
Gastroenterology
70:
326–330,
1976.
|
| 541. |
Snape, W. J., Jr.,
S. L. Matarazzo, and
S. Cohen.
Effect of eating and gastrointestinal hormones on human colonic myoelectrical and motor activity.
Gastroenterology
75:
373–378,
1978.
|
| 542. |
Snider, R. M.,
C. Forray,
M. Pfenning, and
E. Richelson.
Neurotensin stimulates inositol phospholipid metabolism and calcium mobilization in murine neuroblastoma clone N1E–115.
J. Neurochem.
47:
1214–1218,
1986.
|
| 543. |
Sninsky, C. A.,
M. M. Wolfe,
J. L. Martin,
B. A. Howe,
T. M. O'Dorisio,
J. E. McGuigan, and
J. R. Mathias.
Myoelectric effects of vasoactive intestinal peptide on rabbit small intestine.
Am. J. Physiol.
244
(Gastrointest. Liver Physiol. 7):
G46–G51,
1983.
|
| 544. |
Stacher, G.,
P. Bauer,
H. Steinringer,
G. Schmierer,
B. Langer, and
S. Winklehner.
Dose‐related effects of the synthetic Met‐enkephalin analogue FK 33–824 on esophageal motor activity in healthy humans.
Gastroenterology
83:
1057–1061,
1982.
|
| 545. |
Stanghellini, V.,
J. R. Malagelada,
A. R. Zinsmeister,
V. L. W. Go, and
P. C. Kao.
Effect of opiate and adrenergic blockers on the gut motor response to centrally acting stimuli.
Gastroenterology
87:
1104–1113,
1984.
|
| 546. |
Steigerwalt, R. W.,
I. D. Goldfine, and
J. A. Williams.
Characterization of cholecystokinin on bovine gallbladder membranes.
Am. J. Physiol.
247
(Gastrointest. Liver Physiol. 10):
G709–G714,
1984.
|
| 547. |
Stewart, J. J.
Neostigmine antagonist of morphine's effects on intestinal transit.
J. Pharm. Pharmacol.
34:
405–407,
1982.
|
| 548. |
Stewart, J. J., and
T. F. Burks.
Actions of pentagastrin on smooth muscle of isolated dog intestine.
Am. J. Physiol.
239
(Gastrointest. Liver Physiol. 2):
G295–G299,
1980.
|
| 549. |
Stewart, J. J., and
C. D. Curd.
Antipropulsive effects of central and peripheral morphine in the rat gastrointestinal tract.
J. Pharm. Pharmacol.
36:
476–477,
1984.
|
| 550. |
Stewart, J. M.
Problems in the use of substance P. In:
Substance P Dublin 1983,
edited by
P. Skrabanek and
D. Powell.
Dublin:
Boole,
1983,
p. 6–7.
|
| 551. |
Stewart, J. M., and
M. E. Hall.
Central modulation of blood pressure by N‐ and C‐terminal fragments of substance P. Substance P and Neurokinins Montreal 1986 Proc.
1986,
p. 47.
|
| 552. |
Stroes, J. W., and
A. Bast.
Additional binding site for N‐terminal sequence? Functional receptors and binding sites for tachykinins (Letter to the editor).
Trends Pharmacol. Sci.
7:
302,
1986.
|
| 553. |
Strunz, U.,
W. Domschke,
S. Domschke,
P. Mitznegg,
E. Wunsch,
E. Jaeger, and
L. Demling.
Potentiation between 13‐nle‐motilin and acetylcholine on rabbit pyloric muscle in vitro.
Scand. J. Gastroenterol.
11:
29–33,
1976.
|
| 554. |
Strunz, U.,
P. Mitznegg,
W. Domschke,
N. Subramanian,
S. Domschke, and
E. Wunsch.
Acid releases motilin from human duodenum in vitro.
Acta Hepato‐Gastroenterol.
24:
456–457,
1977.
|
| 555. |
Svoboda, M.,
A. Gregoire,
C. Yanaihara,
N. Yanaihara, and
J. Christophe.
Identification of two pro‐VIP forms in a human neuroblastoma cell line.
Peptides Fayetteville
7,
Suppl. 1:
7–15,
1986.
|
| 556. |
Szolcsanyi, J., and
L. Bartho.
New type of nerve‐mediated cholinergic contractions of the guinea‐pig small intestine and its selective blockade by capsaicin.
Naunyn‐Schmiedeberg's Arch. Pharmacol.
305:
83–90,
1978.
|
| 557. |
Szolcsanyi, J., and
L. Bartho.
Impaired defense mechanism to peptic ulcer in the capsaicin‐desensitized rat.
Adv. Physiol. Sci.
15:
39–51,
1981.
|
| 558. |
Szurszewski, J. H.
Mechanism of action of pentagastrin and acetylcholine on longitudinal muscle of the canine antrum.
J. Physiol. Lond.
252:
335–361,
1975.
|
| 559. |
Takemori, A. E.,
M. Ikeda, and
P. S. Portuguese.
The ä‐, κ‐ and δ‐properties of various opioid agonists.
Eur. J. Pharmacol.
123:
357–361,
1986.
|
| 560. |
Takemori, A. E., and
P. S. Portoghese.
Receptors for opioid peptides in the guinea‐pig ileum.
J. Pharmacol. Exp. Ther.
235:
389–392,
1985.
|
| 561. |
Tam, S. W.
Naloxone‐inaccessible à‐receptor in rat central nervous system.
Proc. Natl. Acad. Sci. USA
80:
6703–6707,
1983.
|
| 562. |
Tange, A.
Distribution of peptide‐containing endocrine cells and neurons in the gastrointestinal tract of the dog: immunohistochemical studies using antisera to somatostatin, substance P, vasoactive intestinal polypeptide, Met‐enkephalin, and neurotensin.
Biomed. Res.
4:
9–14,
1983.
|
| 563. |
Tatemoto, K.,
J. M. Lundberg,
H. Jörnvall, and
V. Mutt.
Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin.
Biochem. Biophys. Res. Commun.
128:
947–953,
1985.
|
| 564. |
Tatemoto, K., and
V. Mutt.
Isolation and characterization of a novel intestinal peptide porcine PHI(PHI‐27), a new member of the glucagon‐secretin family.
Proc. Natl. Acad. Sci. USA
78:
6603–6607,
1981.
|
| 565. |
Tatemoto, K.,
A. Rokaeus,
H. Jörnvall,
T. J. McDonald, and
V. Mutt.
Galanin—a novel biologically active peptide from porcine intestine.
FEBS Lett.
164:
124–128,
1983.
|
| 566. |
Taylor, G. S., and
R. A. R. Bywater.
Antagonism of non‐cholinergic excitatory junction potentials in the guinea‐pig ileum by a substance P analogue antagonist.
Neurosci. Lett.
63:
23–26,
1986.
|
| 567. |
Teitelbaum, D. H.,
T. M. O'Dorisio,
W. E. Perkins, and
T. S. Gaginella.
Somatostatin modulation of peptide‐induced acetylcholine release in guinea pig ileum.
Am. J. Physiol.
246
(Gastrointest. Liver Physiol. 9):
G509–G514,
1984.
|
| 568. |
Telford, G. L.,
V. L. W. Go, and
J. H. Szurszewski.
Effect of central sympathectomy on gastric and small intestinal myoelectric activity and plasma motilin concentrations in the dog.
Gastroenterology
89:
989–95,
1985.
|
| 569. |
Telford, G. L.,
M. Hoshmonai,
A. J. Moses, and
J. H. Szurszewski.
Morphine initiates migrating myoelectric complexes by acting on peripheral opioid receptors.
Am. J. Physiol.
249
(Gastrointest. Liver Physiol. 12):
G557–G562,
1985.
|
| 570. |
Telford, G. L.,
S. S. Mir,
G. R. Mason, and
H. S. Ormsbee.
Neural control of canine pylorus.
Am. J. Surg.
137:
92–98,
1979.
|
| 571. |
Thor, P.,
R. Krol,
S. J. Konturek,
D. H. Coy, and
A. V. Schally.
Effect of somatostatin on myoelectrical activity of small bowel.
Am. J. Physiol.
235
(Endocrinol. Metab. Gastrointest. Physiol. 4):
E249–E254,
1978.
|
| 572. |
Tobe, T.,
A. Yamahiro,
T. Manabe,
M. Noguchi,
K. Akaji, and
H. Yajima.
Gastrin releasing peptide in the human stomach.
Acta Histochem. Cytockem.
15:
102–106,
1982.
|
| 573. |
Tokimasa, T.,
E. Cherubini, and
R. A. North.
Nicotinic depolarization activates calcium dependent gκ in myenteric neurons.
Brain Res.
263:
57–62,
1983.
|
| 574. |
Toouli, J.,
I. C. Roberts‐Thompson,
J. Dent, and
J. Lee.
Manometric disorders in patients with suspected sphincter of Oddi dysfunction.
Gastroenterology
88:
1243–1250,
1985.
|
| 575. |
Torphy, T. J.,
C. F. Fine,
M. Burman,
M. S. Barnette, and
H. S. Ormsbee III.
Lower esophageal sphincter relaxation is associated with increased cyclic nucleotide content.
Am. J. Physiol.
251
(Gastrointest. Liver Physiol. 14):
G786–G793,
1986.
|
| 576. |
Tucker, J. F.
Effect of pertussis toxin on normorphine‐dependence and on acute inhibitory effects of normorphine and Clonidine in guinea‐pig isolated ileum.
Br. J. Pharmacol.
83:
326–328,
1984.
|
| 577. |
Uddman, R.,
J. Alumets,
L. Edvinsson,
R. Håkanson, and
F. Sundler.
Peptidergic (VIP) innervation of the esophagus.
Gastroenterology
75:
5–8,
1978.
|
| 578. |
Vizi, E.,
G. Bertaccini,
M. Impicciatore, and
J. Knoll.
Evidence that acetylcholine released by gastrin and related polypeptides contributes to their effect on gastrointestinal motility.
Gastroenterology
64:
268–277,
1973.
|
| 579. |
Vizi, E. S.,
K. Ono,
V. Adam‐Vizi,
D. Duncalf, and
F. F. Foldes.
Presynaptic inhibitory effect of Met‐enkephalin on [14C]‐acetylcholine release from the myenteric plexus and its interaction with muscarinic negative feedback inhibition.
J. Pharmacol. Exp. Ther.
230:
493–499,
1984.
|
| 580. |
Volle, R. L.
Blockade by 9‐aminoacridine of potassium fluxes in frog sartorius muscle.
Biochem. Pharmacol.
20:
315–320,
1971.
|
| 581. |
Wali, F. A.
Possible involvement of substance P in the contraction produced by periarterial nerve stimulation in the rat ileum.
J. Auton. Pharmacol.
5:
143–148,
1985.
|
| 582. |
Walsh, J. H.
Gastrointestinal hormones. In:
Physiology of the Gastrointestinal Tract
(1st ed.),
edited by
L. R. Johnson.
New York:
Raven,
1981,
p. 181–254.
|
| 583. |
Wang, S. C.,
B. H. Du,
J. Eng,
M. Chang,
J. D. Hulmes,
Y. C. E. Pan, and
R. S. Yalow.
Purification of dog VIP from a single animal.
Life Sci.
37:
979–983,
1985.
|
| 584. |
Ward, S. J., and
A. E. Takemori.
Relative involvement of receptor subtypes in opioid‐induced inhibition of gastrointestinal transit in mice.
J. Pharmacol. Exp. Ther.
224:
359–363,
1983.
|
| 585. |
Waterfall, W. E.
Electrical patterns in the human jejunum with and without vagotomy: migrating myoelectric complexes and the influence of morphine.
Surgery St. Louis
94:
186–189,
1983.
|
| 586. |
Weisbrodt, N. W.,
S. E. Sussman,
J. J. Stewart, and
T. F. Burks.
Effect of morphine sulfate on intestinal transport and myoelectric activity of the small intestine of the rat.
J. Pharmacol. Exp. Ther.
214:
333–338,
1980.
|
| 587. |
Werling, L. L.,
S. R. Brown,
P. Puttfarcken, and
B. M. Cox.
Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea‐pig cortical membranes.
Mol. Pharmacol.
30:
90–95,
1986.
|
| 588. |
White, J. D.,
K. D. Stewart,
J. E. Krause, and
J. F. McKelvy.
Biochemistry of peptide‐secreting neurons.
Physiol. Rev.
65:
553–606,
1985.
|
| 589. |
Williams, J. T., and
R. A. North.
Vasoactive intestinal polypeptide excites neurones of the myenteric plexus.
Brain Res.
175:
174–177,
1979.
|
| 590. |
Wingate, D. L.
Backwards and forwards with the migrating complex.
Dig. Dis. Sci.
26:
641–666,
1981.
|
| 591. |
Wong, C. L.
The possible involvement of adrenoceptors in the intestinal effect of morphine in mice.
Clin. Exp. Pharmacol. Physiol.
11:
605–610,
1984.
|
| 592. |
Wood, J. D.
Enteric neurophysiology.
Am. J. Physiol.
247
(Gastrointest. Liver Physiol. 10):
G585–G598,
1984.
|
| 593. |
Yagamishi, T., and
H. T. Debas.
Cholecystokinin inhibits gastric emptying by acting on both proximal stomach and pylorus.
Am. J. Physiol.
234
(Endocrinol. Metab. Gastrointest. Physiol. 3):
E375–E378,
1978.
|
| 594. |
Yajima, H.,
J. Iwai,
H. Watanabe,
K. Koyama, and
N. Nakamura.
Studies on peptides. LXXI.
Chem. Pharm. Bull. Tokyo
25:
2048–2054,
1977.
|
| 595. |
Yanaihara, N.,
N. Sugiura,
K. Kashimoto,
T. Naruse,
C. Yanaihara, and
T. Solomon.
Synthetic and structure‐function study on the C terminal segments of CCK and gastrin.
Peptides Fayetteville
26:
373–378,
1984.
|
| 596. |
Yanaihara, N.,
C. Yanaihara,
K. Nagai,
H. Sato,
F. Shimizu,
K. Yamaguchi, and
K. Abe.
Motilin‐like immunoreactivity in porcine, canine and human and rat tissues.
Biomed. Res.
1:
76–83,
1980.
|
| 597. |
Yau, W. M.,
J. A. Dorsett, and
M. L. Youther.
Inhibitory peptidergic neurons: functional difference between somatostatin and enkephalin in myenteric plexus.
Am. J. Physiol.
250
(Gastrointest. Liver Physiol. 13):
G60–G63,
1986.
|
| 598. |
Yau, W. M.,
P. F. Lingle, and
M. L. Youther.
Modulation of cholinergic neurotransmitter release from myenteric plexus by somatostatin.
Peptides Fayetteville
4:
49–53,
1983.
|
| 599. |
Yau, W. M.,
G. M. Makhlouf, and
L. E. Edwards.
Mode of action of cholecystokinin and related peptides on gallbladder muscle.
Gastroenterology
65:
451–456,
1973.
|
| 600. |
Yau, W. M., and
M. L. Youther.
Direct evidence for a release of acetylcholine from the myenteric plexus of guinea‐pig small intestine by substance P.
Eur. J. Pharmacol.
81:
665–668,
1982.
|
| 601. |
Yoshimura, K.,
J. P. Huidobro‐Toro,
N. M. Lee,
H. H. Loh, and
E. L. Way.
Kappa‐opioid properties of dynorphin and its peptide fragments on the guinea‐pig ileum.
J. Pharmacol. Exp. Ther.
222:
71–79,
1982.
|
| 602. |
Yoshimura, K.,
J. P. Huidobro‐Toro, and
E. L. Way.
Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid‐like alkaloids on the guinea‐pig ileum.
Eur. J. Pharmacol.
84:
17–24,
1982.
|
| 603. |
Zarbin, M. A.,
J. T. Warmsley,
R. B. Innis, and
M. J. Kuhar.
Cholecystokinin receptors: presence and axonal flow in the rat vagus nerve.
Life Sci.
29:
697–705,
1981.
|
| 604. |
Zetler, G.
Antagonism of cholecystokinin‐like peptides by opioid peptides, morphine or tetrodotoxin.
Eur. J. Pharmacol.
60:
67–77,
1979.
|
| 605. |
Zwick, R.,
K. L. Bowes,
E. E. Daniel, and
S. K. Sarna.
Mechanism of action of pentagastrin on the lower esophageal sphincter.
J. Clin. Invest.
57:
1644–1651,
1976.
|
